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ABSTRACT

Cholesterol is a versatile molecule that determines the biophysical properties of cellular
membranes and regulates various signalling pathways. Cholesterol has also been implicated in
synaptic development. In vitro studies have shown that reducing cholesterol levels can increase
or decrease neurite outgrowth in different types of cultured neurons. However, the underlying
mechanisms of how reduced cholesterol content of membranes affects synaptic growth have not
been explored in detail. Cholesterol has been shown to regulate the cAMP-protein kinase A (PKA)
pathway in non-neuronal cells. The cAMP-PKA pathway is known to be an important regulator of
synaptic development. My primary objective was to elucidate the cellular mechanisms by which
cholesterol regulates

synaptic growth.

I extracted cholesterol from Drosophila larval

neuromuscular junctions in controls and mutants known to be involved in cAMP-PKA signalling
and then examined the effects that this had on synaptic growth. First, I found that cholesterol is
required for the normal synaptic growth. Second, chronic and acute cholesterol extraction reduced
PKA activity. Next, I extracted cholesterol from mutants with elevated cAMP levels and found
that synaptic growth was also reduced in these mutants, suggesting cholesterol may be acting
downstream of cAMP. Furthermore, I found that cholesterol was required for activity-dependent
synaptic growth, which is known to be regulated by cAMP-PKA signalling. Lastly, I constructed
a vector based on domain four of the theta-toxin produced by Clostridium perfringens to serve as
a genetically encoded cholesterol biosensor to determine the distribution of cholesterol at the
Drosophila larval neuromuscular junction. Overall, my results suggest that cholesterol-dependent
effects on synaptic growth may be due to changes in cAMP-PKA signalling. My findings
demonstrate that changes in the cholesterol content of neurons can affect synaptic development,
which in turn could result in synaptic dysfunction.
iv
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CHAPTER 1: GENERAL INTRODUCTION AND OVERVIEW

1

1.1 Neuroscience:
Research in neuroscience, the study of the nervous system, is fundamental to understand
the properties of neurons and neural circuits. It involves studying the cellular and molecular
biology, physiology, and anatomy of the nervous system, as well as learning, memory, and
behavioural neuroscience. In the twentieth century, advances in molecular biology,
electrophysiology, and computational technology allowed scientists to study the nervous system
in all aspects, from structure to development to function. However, due to the high degree of
plasticity, the formation of synapses and lifelong changes in the nervous system makes this
dynamic system a formidable research challenge. Thus, one of the major challenges in
neuroscience today is to explain the mechanism that directs the development of the nervous
system.
1.1.1 Nervous system:
The nervous system is the central controlling, regulatory, and communicating system in
the body. The primary nerve cells found in the nervous system are called neurons, which consist
of a cell body that contains the nucleus and an axon that carries information away from the cell
body. At the most basic level, the primary function of the nervous system is to transfer information.
Unlike hormones released into circulation, the nervous system sends information to specific target
cells through synaptic connection, thus providing a higher level of specificity at an increased
speed.
Even though the nervous systems of different organisms perform the same primary
function, the structure and complexity differ. In vertebrates, the nervous system is divided into two
parts: the central nervous system, which consists of the brain and spinal cord, and the peripheral
nervous system, which contains nerves that carry information to and from the central nervous
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system. Invertebrate nervous systems are less complex than those of vertebrates. Because of this
simplicity, invertebrates have served as model organisms to elucidate fundamental principles of
neuronal system biology, such as the basis of action potentials, synaptic transmission, and axon
pathfinding (Atwood and Karunanithi, 2002; Südhof and Rizo, 2011; Südhof; 2012; Chanaday et
al., 2019; Russell and Bashaw, 2018).
1.1.2 Synaptic structure and connectivity:
In the nervous system, neurons can transmit signals to neurons or other cell types through
specialized junctions called synapses. A synapse is an individual, specialized close contact
between presynaptic and postsynaptic membranes, which permits neurons to pass an electrical or
chemical signal to target the cell (Thomson, 2000; Atwood and Karunanithi, 2002). The nervous
system consists of two different types of synapses. In electrical synapses, cell membranes are
connected through gap junctions. This is a channel that allows the rapid transfer of signals in the
form of electrical current to pass by causing a voltage change in the presynaptic cell to a
postsynaptic cell (Thomson, 2000; Atwood and Karunanithi, 2002). In contrast, chemical synapses
convert the electrical activity through voltage-gated channels into the release of chemical
neurotransmitters. These neurotransmitters bind to the plasma membrane of postsynaptic cells.
Additionally, synapses can consequently be classified based on the neurotransmitter they release,
such as glutamatergic synapses that release an excitatory glutamate neurotransmitter (Davis and
Murphey, 1994).
Active zones are sites of neurotransmitter release in the presynaptic axon terminal or
synaptic bouton. Active zones are composed of a dense collection of proteins called the cytomatrix
that tether synaptic vesicles to the plasma membrane (Zenisek et al., 2000; Ahmari et al., 2000).
Vital proteins that are known to be enriched in the active zones are UNC13B/Munc13, Bassoon,
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Piccolo/aczonin, RIMS1 (Rab3-interacting molecule), and liprins-α (Südhof, 2012). These
proteins serve as scaffold proteins and are components of the dense pyramid-like structures which
function to bring synaptic vesicles into close proximity to the plasma membrane and calcium
(Ca2+) channels (Zenisek et al., 2000, Ahmari et al., 2000). As seen in Figure 1.1, this highly
organized complex of proteins along with the lipid membrane located at active zones are required
for synaptic vesicle fusion and the release of neurotransmitters into the synaptic cleft (Zenisek et
al., 2000, Ahmari et al., 2000; Atwood and Karunanithi, 2002).
1.1.3 Mechanisms of neurotransmission:
Neurotransmitter release can occur either by evoked neurotransmission in response to an action
potential or through the spontaneous fusion of synaptic vesicles in the absence of action potential
(also known as “minis”). Several studies suggest that the signal from spontaneous neurotransmitter
release is required for maturation and stability of synaptic networks, inhibition of dendritic protein
synthesis or even might be responsible for action potential firing in cells with high membrane
resistance (Glitsch et al., 2008).
In chemical synapses, neurotransmitters are synthesized in the cell body of neurons, packaged
into vesicles, and transported to the presynaptic terminal through an axon. Vesicles are then docked
by physically coming in contact with the plasma membrane and then primed so that they are readyto-fuse upon signal. Fusion is mediated by the Soluble NSF Attachment Protein Receptor
(SNARE) complex and the calcium-binding protein, synaptotagmin (Ahmari et al., 2000; Südhof,
2014). SNARE proteins include the synaptic vesicle protein synaptobrevin 2 (syb-2/VAMP2),
syntaxin, and SNAP-25. As the Ca2+ ions bind to synaptotagmin, it unclamps the SNARE complex
triggering synaptic vesicle fusion with the presynaptic terminal membrane (Südhof, 2012). Active
zones or electron-dense projections of various shapes such as T-shaped structures extend into the
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presynaptic cytoplasm where vesicles are released (Wagh et al., 2006). Bruchpilot (BRP) is a vital
element of the T-bar at Drosophila synapses. Imaging has shown that a single BRP protein reaches
from the active zone membrane into the cytosol of boutons, thus resulting in its T shape
morphology (Ackermann et al., 2015). Following synaptic vesicle fusion, neurotransmitters
diffuse through the synaptic cleft and attach to receptors on the postsynaptic terminal such
as ligand-gated ion channels and G-protein coupled receptors (Atwood and Karunanithi, 2002;
Südhof, 2014). These neurotransmitters binding then induces a change in the postsynaptic cell,
thus resulting in neurotransmission.
Binding of neurotransmitters may act to inhibit or stimulate the postsynaptic neuron. The
stimulation of excitatory receptors upon neurotransmitter binding on the postsynaptic neuron or
muscle causes depolarization of the postsynaptic membrane, promoting the generation of an action
potential and allowing the message to move on. Conversely, stimulation of inhibitory receptors on
the postsynaptic neuron or muscle causes hyperpolarisation of the postsynaptic membrane,
repressing the generation of an action potential. Additionally, neurotransmitter binding can
mediate short-term changes, such as changes in postsynaptic potential or long term changes
through the activation of signalling cascades.
G-protein-coupled receptors (GPCRs) are one of the primary ways to regulate the
neurotransmitter release at the presynaptic terminal (Lovinger, 2008). It is known that the
activation of GPCRs at the presynaptic terminal can reduce neurotransmitter release (Lovinger,
2008). This involves the activation of G-proteins that regulate different inhibitory mechanisms
such as inhibition of voltage-gated Ca2+ channels, activation of K+ channels, or directly regulating
vesicle fusion processes (Lovinger, 2008). For example, endocannabinoids can bind to the GPCR
on the presynaptic terminal, causing short-term or long-term synaptic depression through a
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decrease in neurotransmitter release (Lovinger, 2008). Moreover, GPCRs are also known to act on
the signalling molecules such as cyclic adenosine monophosphate (cAMP), who can in turn act on
cAMP-response element-binding protein (CREB) that regulates the expression of genes known to
be involved in the synaptic development (Wang et al., 2018).
Additionally, neurotransmitters play a central role in shaping the nervous system throughout
development (Herlenius and Lagercrantz, 2004; Huntwork and Littleton, 2007). For example,
spontaneous neurotransmitter release that occurs independently of an action potential at synapses
is regulated by complexin (cpx), a SNARE complex–binding protein. Studies have found that the
cpx null mutants have increased spontaneous neurotransmitter and nerve terminal overgrowth
(Huntwork and Littleton, 2007; Cho et al., 2015). This suggests that synaptic neuronal connections
may be, in part, regulated by the spontaneous neurotransmission.
1.2 Development and neurobiology of Drosophila:
Drosophila has been a favoured model organism for neuroscientists because it possesses ideal
features for an experimental organism. It has a shorter life span, small size, cheap to maintain in
large numbers and is anatomically simple. In modern times, immunohistochemistry-based
anatomy with electrophysiological studies has demonstrated that the Drosophila larval
neuromuscular junction (NMJ) is an excellent genetic model to study synaptic function and
development (Harris and Littleton, 2015; Shin et al., 2018). Easy genetic manipulations in
Drosophila have made it an extremely appealing model system. The systematic large-scale
screening of early development of the Drosophila neuromuscular system could serve as a model
to study axonal growth and synapse formation (Miller et al., 2012; Shin et al., 2018).
1.2.1 Drosophila as model system:
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For decades, the fruit fly Drosophila melanogaster, in order Diptera and family
Drosophilidae, has been used as a model organism for biological research because of the high
degree of evolutionary conservation (Bellen et al., 2010; Hales et al., 2015). For the last 50
years, Drosophila has been systematically used to understand and discover principle mechanisms
underlying fundamental biological processes such as development, cell-cycle regulation,
signalling pathways, and synaptic growth and functions (Shin et al., 2018). Also, fly genetics has
been transformed with the advent of molecular technology, gene sequencing, transgenic knockdown constructs and recombination-based strategies for the generation of mutants (Hales et al.,
2015).
Drosophila is easily cultured in the lab and can have many offspring in a short generation
period (Shin et al., 2018). The process of development from fertilized egg to adults requires an
average of 9-10 days (Fig. 1.2). After fertilization, embryogenesis is completed in approximately
24 hours, followed by three larval stages, with first two lasting one day and last stage lasting two
days. Thus, after five days of fertilization, Drosophila larvae metamorphose within a hard pupal
case, with steroid hormone ecdysone playing a vital role during this transformation (Hales et al.,
2015; Shin et al., 2018). Drosophila remains in the pupal case for 4-5 days and emerges as an
adult, requiring an additional 8-12 hours to sexually mature (Hales et al., 2015).
Drosophila was the second organism to be sequenced, following only C. elegans, with
approximately 13,600 genes (McGurk et al., 2015). This enabled the fly community to establish
and access large datasets that contain information on the Drosophila genome, transcriptome,
regulatory elements, thus making Drosophila an excellent experimental system to answer
questions about the development and function of the genes in an organism. Since most of the
human genes linked with various diseases have a Drosophila counterpart, this makes the
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Drosophila genetic analysis is critical for research in human health (McGurk et al., 2015; Hales et
al., 2015). This is because, at the basic level, the molecular mechanisms associated with pathways
such as neural responses in Drosophila are shared with humans, thus making it an invaluable tool
(McGurk et al., 2015).
1.2.2 Neuromuscular junction of Drosophila:
Drosophila NMJs are an ideal system to examine cellular and molecular mechanisms that
underlie developmental processes (Shin et al., 2018). NMJs have a number of synaptic
connections where information is transmitted from the presynaptic endings of motor neurons to
the muscle. Abdominal segments of larval NMJs are composed of simple and easily accessible
overlapping, striated fibres attached to the surface of body wall at a specific location (Keshishian
et al., 1996; Miller et al., 2012). Each muscle in larvae is a multinucleated cell, formed by nearby
myoblasts merging (Keshishian et al., 1996; Miller et al., 2012). During the late stages of
embryonic development, motor neurons spread their axons into the musculature (Miller et al.,
2012). The segmental, intersegmental nerve roots and the transverse nerve are the three pathways
that the motor neurons take to leave the central nervous system (Keshishian et al., 1996; Menon et
al., 2013), following a genetically determined route to a specific muscle fibre. The axonal growth
cones extend to the target muscle, where then growth cones differentiate into the presynaptic
terminal (Miller et al., 2012). Thus, by the last embryonic development stage, a functional NMJ
containing synaptic boutons forms on each muscle fibre (Menon et al., 2013).
The larval NMJ consists of a simple configuration consisting of abdominal hemisegments
from A2 to A7, of around 36 motor neurons and 30 muscles (Landgraf and Thor, 2006), in a highly
stereotyped and segmented way. These boutons in Drosophila mainly release glutamate as an
excitatory neurotransmitter, with a small subset expressing transmitters such as octopamine and
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neuropeptide called proctolin (Keshishian et al., 1996; Menon et al., 2013). Additionally, larval
motor neurons fall into three classes: type I, type II and type III, based on the size of their boutons
and anatomy, as depicted in figure 3. Type I boutons are glutamatergic, type II and III are
modulatory and use other neurotransmitters (Atwood et al., 1993). There are two main types of
types I of glutamatergic motor neurons: 1b and 1s. Type 1s and 1b are both motor excitatory and
glutamatergic and are subdivided into 1b (3-5μm) and 1s (1-3μm) based on the size, as depicted
in figure 1.3 (Atwood et al., 1993). Additionally, type II presynaptic terminals are smaller. They
have longer branches than type I terminals and type III display elongated or elliptical presynaptic
terminals with intermediate size between type I and II (Perez-Moreno and O’Kane et al., 2019).
Most synaptic studies have focused on performing the experimentation on the larval abdominal
ventral longitudinal muscles of muscles 6 and 7. At this section of the larvae, the NMJ is large and
positioned on the surface of dissected preparation (Menon et al., 2013).
1.2.3 Approaches to study Drosophila NMJ development:
Drosophila mutants and transgenic flies have been instrumental in the investigation of the
nervous system's complexity through sophisticated genetic manipulations. The GAL4-upstream
activating sequence (UAS) system can be used selectively express transgenes in specific tissues
(Fig. 1.4). To express the desired transgene in a particular tissue, driver flies that contain the tissuespecific promoter of upstream of the gene encoding the yeast GAL4 transcription factor and flies
containing the corresponding UAS binds that can bind to GAL4 (Brand and Perrimon, 1993). Thus,
the transgenic flies that only contain one of the two constructs do not express the desired genotype.
However, when crossed, GAL4 drives the expression of the UAS transgene, which allows the
transcription of the gene of interest in the specified tissue (Hales et al., 2015). Additionally,
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fluorescent effectors such as GFP reporters can easily be used to visualize anatomy or
electrophysiological recordings using the GAL4/UAS system.
1.3 Synaptic membranes:
Like other cellular membranes, the presynaptic and postsynaptic plasma membranes are
composed of both lipids and proteins (Lasiecka et al., 2008; Sezgin et al., 2017). The phospholipid
bilayer serves as the foundation of the synaptic membrane by serving as a barrier between two
aqueous counterparts of inside and outside of the cell (Sezgin et al., 2017). This bilayer structure
of the membrane contains hydrophobic fatty acid chains, glycolipids, phospholipids, and
cholesterol distributed between two leaflets of the plasma membrane (Lasiecka et al., 2008). Even
though lipids form the synaptic membrane's structural foundation, it is the proteins embedded in
the membrane that carry out the specific functions. Thus, proteins such as adhesion molecules, G
protein-coupled receptors, signalling receptors, voltage-gated channels, ligand-gated channels, and
other functional protein complexes allow the signal propagation in neuronal circuits (Lasiecka et
al., 2008; Sezgin et al., 2017). Therefore, the synaptic plasma membrane, along with its
component, is crucial for performing specific functions such as action potential transmission,
neurotransmitter release, and development.
1.3.1 Synaptic membrane lipids:
Normal neuronal function is dependent on the proper assembly of membrane lipids for
lipid-based signalling. Lipids can be divided into simple lipids such as fatty acid and sterols such
as cholesterol, and complex lipids such as glycerophospholipids and sphingolipids (Fahy et
al., 2005). The role of lipids at the membrane is dependent on its unique biophysical properties.
Lipids are small amphipathic molecules that can self-assemble in water. They are composed of a
small negatively-charged head group with a hydrophobic tail that gives rise to membrane
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curvature. Additionally, the presynaptic membrane can remodel their membrane phospholipids by
using phospholipases to control biophysical properties such as curvature, fluidity, thickness, and
through the release of signalling molecules (Puchkov and Volker, 2013; Lauwers et al., 2016).
At synapses, lipids have also been known to play a significant role in synaptic vesicle
endocytosis and processes. Synaptic plasma membranes are extensively reconstructed for the
formation of synaptic vesicles during endocytosis, the release of neurotransmitters through fusion
with the membrane, and synaptic events that require the opening of ion channels. Proteins involved
in the priming and docking of synaptic vesicles tend to bind to the negatively charged lipids in the
membrane, such as phosphatidylinositol phosphates (Lauwers et al., 2016). Moreover, exocytosis
also requires synaptic membrane fusion between the vesicles and the plasma membrane. SNARE
complexes (Fig. 1.1), composed of synaptobrevin, syntaxin, and SNAP-25 proteins, regulate this
process through the assistance of membrane lipids and proteins (Rohrbough and Broadie 2005).
For example, phosphatidylinositol phosphates and phosphatidylserine bind to synaptobrevin and
syntaxin during vesicle docking, assisting in the regulation of synaptic vesicle exocytosis
(Darios et al., 2007). Furthermore, phosphatidylinositol (PtdIns), membrane lipids that can give
rise to seven different PtdIns through phosphorylation at three different positions, are also known
to regulate transmembrane and peripheral membrane proteins at terminals (Lauwers et al., 2016).
PtdIns are known to regulate calcium-stimulated exocytosis, clustering of syntactic vesicles in the
presynaptic terminal, and playing a role in clathrin-dependent endocytosis (Lauwers et al., 2016).
Hence, PtdIns play a vital role in driving the synaptic vesicle cycle, regulating ion channels, and
regulating presynaptic protein interaction.
Through biochemical experiments and observations on cholesterol’s close association with
the phospholipids and sphingolipids in the plasma membrane came the concept of lipid raft
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hypothesis (Korade and Kenworthy, 2008). This hypothesis states that the cholesterol and
sphingolipids are part of membrane nanodomains located in the plasma membrane (Korade and
Kenworthy, 2008; Maekawa and Fairn, 2015). Thus, lipid rafts are specialized membrane
microdomains involved in the assembly of signalling molecules, facilitating cell signalling
cascades, regulating exocytic and endocytic pathways, controlling fluidity of the membrane,
trafficking and sorting of proteins, and regulation of different cellular processes such as
neurotransmitter release (Tsui-Pierchala et al., 2002; Korade and Kenworthy, 2008).
It has been proposed that lipid rafts are the structures that regulate the neurotransmitter
signalling through clustering components of signalling cascades (Tillman and Cascio, 2003). The
localization of these proteins and cholesterol in lipid rafts affects the efficiency of neurotransmitter
receptors and transporters. It has been studied that altered sterol production leads to altered
organization and composition of lipid rafts, resulting in a disruption in neurotransmitter release
(Tillman and Cascio, 2003; Allen et al., 2007). Cholesterol-synaptophysin-synaptobrevin
interaction is thought to recruit and segregate essential synaptic vesicle-specific proteins from the
plasma membrane (Thiele et al., 2000). Although progress has been achieved in the understanding
components of lipid rafts, we still have little insight into mechanisms through which they might
be involved in neuronal functioning.
1.3.2 Role for sphingolipids at synapse:
Neuronal plasma membranes and endomembrane systems are also enriched in synaptic
membrane lipids called sphingolipids and their derivatives. Sphingolipids are composed of a long
chain of amino-alcohol sphingosine, acting as signalling centres of membranes (West et al., 2018).
It is known that the sphingolipids self-aggregate into membrane domains with cholesterol
(Puchkov and Volker, 2013). Additionally, they are also involved in intracellular transport,
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localization of neurotransmitter receptors, synaptic vesicle exocytosis, axonal outgrowth, protein
localization and responses to oxidative stress (Puchkov and Volker, 2013; West et al., 2018).
Changes in sphingolipid mechanistic pathways have been associated with neuronal plasticity
disruptions (Hussain et al., 2019). Disorder in sphingomyelinase-2, which hydrolyzes
sphingomyelin to ceramide, is known to modulate synaptic activity, in part by controlling the
function of excitatory postsynaptic receptors (Tabatadze et al., 2010; Hussain et al., 2019).
In vitro studies on sphingolipid/cholesterol microdomains have implicated sphingolipids in
neuromuscular synaptic development (West et al., 2018). Recessive and dominant mutations in
serine palmitoyltransferase long chain base subunits (SPT2/SPTLC2), which is essential for
sphingolipid synthesis, results in significant perturbations to gross morphology of NMJ structure.
In addition, EMS induced point mutation in the Drosophila SPTLC2 gene, lace, also decreases
synaptic bouton number and results in an increase in bouton size with no changes in the
ultrastructure of the synapse (West et al., 2018). Huang et al., (2018) also showed that mannosyl
glucosylceramide (MacCer), a species of glycosphingolipid (GSL), promotes synaptic bouton
formation at the NMJ. These findings demonstrate that sphingolipid synthesis is required at the
Drosophila NMJ to regulate synaptic structure and development.
1.3.3 Cholesterol:
Among the presence of a variety of phospholipids and sphingolipids in a synaptic
membrane, cholesterol plays a unique role. Due to its rigid hydrophobic structure and small
headgroups, cholesterol can flip-flop between the bilayer membrane and be easily inserted and
removed by protein carriers (Maekawa and Fairn, 2015). Additionally, due to the hydrophobic
nature of its ring, cholesterol can tightly insert with phospholipids and sphingolipids, thus serving
as an essential component of eukaryotic cell membranes. It helps maintain the permeability,
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integrity, and fluidity of plasma membranes and modulates the activity of intercellular signal
transduction pathways through association with proteins such as the Hedgehog protein (Kuwabara
and Labouesse, 2002). Moreover, it serves as a precursor to steroid hormones, thus playing a vital
role in developmental processes (Huang et al., 2007). In Drosophila, sterols accumulate in high
concentrations in the salivary glands, midgut, imaginal discs, brains, trachea, and ovaries
(Huang et al., 2007). In mammals, cholesterol is essential for the synthesis of hormones, assembly
of the cell membrane, and formation and regulation of lipid rafts, which are necessary for cellular
signalling and synaptic transmission (Vance, 2012). Due to the importance of cholesterol, different
analytical methods to analyse cholesterol can be used for visualization and extraction.
1.3.3.1 Tools for visualizing cholesterol localization:
Localization of cholesterol can be studied by using cholesterol-binding tools. Filipin, a
fluorescent polyene macrolide, can bind to free 3-B-hydroxysterols such as ergosterol and
cholesterol, and can accordingly be used to visualize cellular cholesterol (Friend and Bearer,
1981). Limitations concerning the use of Filipin as a marker is that the efficacy depends on the
microenvironment and its fails to differentiate between cholesterol located in cytosolic or exofacial
leaflets of the plasma membrane (Pfrieger et al., 2003; Maekawa and Fairn, 2015), thus making it
a less ideal cholesterol biomarker.
In this study, I used domain four (D4H) of the theta-toxin made by Clostridium
perfringens to construct a genetically encoded cholesterol biosensor to monitor the distribution of
endogenous cholesterol. Perfringolysin O (PFO) theta-toxin is a cytolysin known to bind to
cholesterol and makes pore formation (Shatursky et al.,1999; Maekawa, 2017). PFO is a protein
that contains four domains, and it is domain 4 (D4) that recognizes the hydroxyl group at position
3 of the cholesterol molecule (Maekawa, 2017). Thus, through the introduced mutations to remove
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its cytotoxicity and increase affinity, researchers have developed cholesterol biosensors named D4
to visualize the distribution of cholesterol in plasma membranes (Maekawa and Fairn, 2015;
Maekawa, 2017).
The fourth domain is a 13 kDa small size segment of this toxin that accurately detects the
cholesterol in the exofacial leaflet of the membrane using microscopy (Maekawa and Fairn, 2015).
The addition of GFP-tagged to D4 can then be utilized to analyze cholesterol’s subcellular
distribution. Furthermore, we specifically used D4H, a D4 domain mutant, which has a higher
affinity for cholesterol in cells (Maekawa and Fairn, 2015). It’s the D4D434S mutant, named D4H,
that is used to image cholesterol in the cytosolic leaflets of the plasma membrane (Maekawa and
Fairn, 2017). Thus, this method to detect cholesterol overcomes the limitation of differentiating
cholesterol localization in the exofacial and cytosolic leaflets of the membrane and is ideal for
live-cell or time-lapse imaging, which is not possible with Filipin (Maekawa and Fairn, 2015).
Hence, D4H is an ideal tool to visualize cholesterol distribution to uncover a new understanding
of cholesterol in synaptic membranes compared to other available methods.
1.3.3.2 Cholesterol-depleting agent:
Extraction of cholesterol from membranes has often been used to study cellular signalling,
membrane fluidity, proteins sorting and trafficking, and membrane permeability (Ilangumaran and
Hoessli, 1998; Mahammad and Parmryd, 2015). Cholesterol depletion can be achieved through
metabolic inhibitors that causes disruption of its biosynthesis such as compactin, lovastatin or
sqalestatin. Otherwise, cholesterol deficient medium or chemicals such as digitonin and saponin
can also be used to extract cholesterol (Mahammad and Parmryd, 2015). Inhibition of cholesterol
synthesis or culture cells in poor cholesterol medium requires treatment over days, allowing time
for remaining cholesterol to redistribute. Furthermore, chemicals to remove cholesterol are not
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usually suitable for working with live cells for example digitonin is a detergent that can make
membranes porous (Mahammad and Parmryd, 2015). Therefore, cyclodextrins (CDs) have
frequently been used for cholesterol extraction acutely or chronically in vivo or in vitro since they
can work fast, don’t degrade, and are compatible with live cell experiments (Ilangumar and
Hoessli, 1998; Swaroop et al., 2012; Mahammad and Parmryd, 2015). CDs are water-soluble
oligosaccharides that contain a hydrophobic cavity to sequester cholesterol in their hydrophobic
core (Fig. 1.5). Unlike other cholesterol-binding agents, CDs are surface-acting and selective for
membrane cholesterol agents (Ilangumaran and Hoessli, 1998). Additionally, there are three
different cyclodextrins (α, β and γ -cyclodextrins) used to change the plasma membrane's sterol
composition. However, it's the methyl-β-cyclodextrin (MβCD) that has been studied to selectively
extract cholesterol (Ilangumaran and Hoessli, 1998).
1.3.3.3 Effects of cholesterol on kinase activity:
Cholesterol is thought to affect the activity of kinases (Smith et al., 2010). However,
directly testing the effects of cholesterol extraction on kinase activity has been difficult to do in
vivo. The development of genetically encoded reporters of kinase activity allows for more direct
evidence of the effects of cholesterol on kinase activity. A recent study measured PKA activity
using the separation of phases-based activity reporter of kinase (SPARK)-PKA, a GFP-based
kinase reporter (Fig. 1.6) that phase-separated upon kinase activation forming fluorescent droplets
(Zhang et al., 2018). In this SPARK-based PKA, reporter flies contain a peptide sequence known
as forkhead-associated domain 1 (FHA1), which is specifically phosphorylated by PKA. Also, this
FHA1 domain is fused with homo-oligomeric tags (HOTags) and PKA reporter gene. Therefore,
to allow for a PKA activity-dependent activity visualization, when PKA is activated, it induces the
formation of protein-protein interactions using HOTags multivalency, hence leading to phase

16

separation and formation of fluorescent droplets. However, when the kinases are inactivated, there
is a diffuse fluorescence. Consequently, transgenic flies with the SPARK reporter can be used to
detect kinase activity.
1.4 Function of cholesterol at synapse:
Cholesterol is essential for the normal function of neuronal membranes. Studies have found
cholesterol in microdomains influences the distribution of a number of presynaptic and
postsynaptic proteins that are involved in synaptic transmission. Cholesterol is thought to be
enriched at presynaptic components such as synaptic vesicles, active zones (sites of exocytosis)
and periactive zone (sites of endocytosis) and postsynaptic terminals.
1.4.1 Cholesterol in presynaptic terminals:
Lipid rafts in the presynaptic terminals contain an elaborate assembly of lipids and proteins
that are essential components of exocytosis machinery for transport and synthesis of
neurotransmitter vesicles. Membrane cholesterol content changes membrane fluidity and structure
(Igbavboa et al., 1996). Inner leaflet of presynaptic terminal membrane's contain eight-fold more
cholesterol than its outer leaflet, thus resulting in the asymmetric distribution in the presynaptic
membrane (Igbavboa et al., 1996). Biochemical studies through experiments such as freezefracture electron microscopy on frog NMJs indicted a high amount of cholesterol in active zone
and a low quantity in the adjacent areas that are enriched in the intramembrane particles (Ko et al.,
1986). An additional study by Surchev et al., (1995) on the rat cerebral cortex also indicated the
presence of cholesterol at presynaptic terminals and an absence from intramembrane particles rich
zones. Moreover, Surchev et al. (1995) also established that the cholesterol concentration at the
presynaptic membrane increases during postnatal development.
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1.4.2 Cholesterol in postsynaptic terminals:
The postsynaptic membrane and postsynaptic density contain proteins that allow for
postsynaptic signal transduction in a cholesterol-dependent manner. Postsynaptic neurotransmitter
receptors are linked to rafts, such as nicotinic acetylcholine receptors (AChRs), α-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors and N-methyl-Daspartate (NMDA) receptor subunits (Pfrieger et al., 2003). For example, AChRs from cultured
chicken ciliary ganglion neurons were found to disperse when cholesterol was extracted using
MβCD (Brusés et al., 2001). This suggests that cholesterol may facilitate the clustering of
postsynaptic receptors via lipid rafts.
1.4.3 Effects of dysregulation of cholesterol biosynthesis and trafficking:
In mammals, cholesterol synthesis starts in the endoplasmic reticulum and is trafficked in
anterograde transport vesicles from the trans-Golgi network with various transporter assistance.
Cholesterol is synthesized from the conversion of acetyl-CoA to 3-hydroxy-3-methylglutaryl-CoA
by HMG-CoA synthase, which is then converted to mevalonate by HMG-CoA reductase, then
followed by series of 19-step enzymatic reactions (Maxfield et al., 2010). In contrast,
in Drosophila and all other insects, cholesterol is unable to be synthesized from simple precursors
(Huang et al., 2005; Niwa et al., 2011). Their genome lacks the enzymes for de novo synthesis.
Thus, they must take cholesterol directly from diet to survive.
It is studied that on a cholesterol-free diet Drosophila, does not develop from the first-instar
larva to the second-instar larva (Parkin and Burnet, 1986), thus implicating the need of cholesterol
for larval growth. This suggests that even though insects don’t synthesize cholesterol, they must
have genetic mechanisms regulating the uptake, trafficking, and conversion of cholesterol to other
essential molecules. For example, to synthesize the primary hormone 20-hydroxyecdysone (20E)
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needed for molting and properly developing and reproducing, cholesterol is obtained from food
(Huang et al., 2007), thus indicating that cholesterol is an essential component of
Drosophila development.
1.4.3.1 Drosophila Niemann-Pick type C genes for cholesterol homeostasis and steroid
biosynthesis:
Previous studies have indicated that the Niemann-Pick type C1 (NPC1) in Drosophila is
involved in cholesterol and lipid homeostasis and is a vital component to synthesize the molting
hormone (20E) (Phillips et al., 2008). A genetic approach to explore the function of cholesterol
in Drosophila has shown that the NPC1 mutants have molting defects and homozygotes do not
develop beyond the first-instar larvae stage because of a deficiency in the molting hormone 20E,
since the precursors of ecdysone biosynthesis are cholesterol and 7-dehydrocholesterol (Huang et
al., 2007). This lethality can be rescued by feeding NPC1 mutant larvae excess 20E or its two
precursors: cholesterol or 7-dehydrocholesterol. NPC1 promotes efficient intracellular trafficking
of sterols to the ER, mitochondria, and organelles of ring gland cells for proper development
(Huang et al., 2007). Mutation in the NPC2 gene also results in an abnormal distribution of sterol
in many cells in Drosophila but does not cause death (Huang et al., 2007). In addition to the defect
in the cholesterol levels, NPC1 mutants have neuronal and behavioural abnormalities such as a
shorter life span compared to the wild type and large vacuoles in the brain, indicating
neurodegeneration (Huang et al., 2007). This suggests that cholesterol is vital for proper
development.
1.4.3.2 DHR96 nuclear receptor regulates cholesterol homeostasis:
DHR96, a Drosophila nuclear receptor responsible for cholesterol homeostasis, is essential
for dietary cholesterol homeostasis (Horner et al., 2009; Niwa et al., 2011). Drosophila DHR96
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nuclear receptor binds to cholesterol and is known to be essential for survival in a low cholesterol
diet and to maintain cholesterol homeostasis during development on a high cholesterol diet
(Horner et al., 2009). Research indicates that there is an increase in DHR96 activity level in low
cholesterol mediums, thus protecting cells in low cholesterol situations (Horner et al., 2009;
Niwa et al., 2011). Furthermore, dietary cholesterol is known to regulate the transcription of genes
and acts to regulate lipid metabolism (Kalaany and Mangelsdor, 2006). Investigations conducted
on DHR96 mutants grown in low-cholesterol mediums have found that certain genes which are
known to play central roles in cholesterol metabolism and transport are up-regulated in response
to cholesterol levels (Horner et al., 2009). Additionally, DHR96 mutants grown on a lowcholesterol diets have been found to arrest their development and die within few days (Horner et
al., 2009), thus indicating that cholesterol is necessary for larval development.
1.4.3.3 Oxysterol binding protein (OSBP) for cholesterol transport, signalling and
metabolism:
Within the cell, cholesterol and other sterols are distributed unevenly, with the most
localization occurring in the plasma membrane (Ma et al., 2010). This uneven distribution of
sterols usually involves both the vesicular and non-vesicular trafficking systems (Ma et al., 2010).
The oxysterol binding protein (OSBP) family, which binds to sterols, is involved in the
intracellular non-vesicular trafficking of cholesterol (Alphey et al., 1998; Ma et al., 2010;
Olkkonen, 2004). For example, OSBP anchors to the Golgi apparatus by interacting with
phosphatidylinositol 4-phosphate (PI4P) and GTPase ADP-ribosylation factor 1 (ARF1) in the
membrane. OSBP also binds specifically to cholesterol for its transport, vesicle trafficking, and
cellular signalling (Ma et al., 2010). Knockdown of these proteins results in defects in the
endoplasmic reticulum to Golgi transport of cholesterol and intracellular transport to other

20

organelles (Alphey et al., 1998; Ma et al., 2010). In Drosophila, OSBP transports sterols between
the intracellular vesicles and the plasma membrane and the lack of sterols in OSBP mutants results
in the absence of mature sperm, which can be restored when supplementing the medium with
cholesterol to recover some fertility and produce more offspring (Ma et al., 2010). Interestingly,
VAP33A, a binding partner of OSBP in Drosophila, is known to affect synaptic growth and
neurotransmitter release through interactions with microtubules and the presynaptic membrane at
the Drosophila larval NMJ (Pennetta et al., 2002). Acyl coenzyme A, cholesterol acyltransferase
genes, and steroidogenic acute regulatory proteins are some of the other cholesterol regulating
elements found in Drosophila for cholesterol regulation (Niwa et al., 2011).
1.5 Regulation of neurotransmission release:
Controlling levels of cholesterol in the membrane is essential for the normal functioning of
many membrane proteins involved in synaptic transmission, such as ion channels, receptors, and
transporters. Thus, alteration of cholesterol content is known to change the fusibility of membrane
and activity of these proteins (Lang, 2001). Internalization, localization, and trafficking of
neurotransmitter receptors are also known to be significantly influenced by cholesterol depletion.
Cholesterol is also vital for the maintenance of synaptic organization, processes of synaptogenesis,
and synaptic vesicle recycling (Pfrienger, 2003).
1.5.1 Effects of cholesterol on evoked neurotransmitter release:
Various studies have applied electrophysiological and optical techniques to examine the
effects of cholesterol depletion on evoked neurotransmitter release. Work by Zamir and Charlton
(2006) revealed that the cholesterol extraction by MβCD blocked evoked neurotransmission at
crayfish neuromuscular junction. Their results demonstrates that cholesterol depletion
hyperpolarizes the presynaptic axon, which in turn blocks the action potential propagation, hence
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halting the action potential-dependent evoked neurotransmitter release. Smith et al. (2010) also
observed a decrease in the amplitude of EPSCs in cerebellar neurons and reduced paired-pulse
ratio after cholesterol extraction, suggesting an increased release probability. These studies
indicate that the blockade of evoked transmitter release by cholesterol extraction is maybe due to
blockade of action potential propagation. Study conducted by Dason et al. (2010) found that the
effect of acute sterol depletion in Drosophila larval NMJ enhanced evoked neurotransmitter
release. The increase in the evoked transmitter release suggests that the application of MβCD does
not impair action potential propagation in Drosophila motor neurons. In summary, these findings
indicate that acute cholesterol removal by MβCD results impairs action potential propagation and
increase evoked neurotransmitter release.
1.5.2 Effects of cholesterol on spontaneous neurotransmitter release:
Corresponding to evoked release, recent studies of the presynaptic machinery have produced
results that support the finding that MβCD application augments spontaneous neurotransmitter
release. Extraction of cholesterol with MβCD increased the frequency of mini excitatory
postsynaptic potentials at the crayfish NMJ (Zamir and Charlton, 2006). Consistent with these
findings, cholesterol extraction from cultured hippocampal and cerebellar neurons also increased
spontaneous neurotransmitter release (Wasser et al., 2007; Wasser and Kavalali, 2009; Smith et
al., 2010). Likewise, the effect of acute cholesterol depletion at the Drosophila larval NMJ also
enhanced the spontaneous neurotransmitter release (Dason et al., 2010). These studies demonstrate
that the level of cholesterol plays an essential role in limiting spontaneous synaptic vesicle release
at synapses (Zamir and Charlton, 2006; Wasser et al., 2007, 2009; Dason et al., 2010, 2014;
Teixeira et al., 2012).
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These changes in synaptic transmission, especially the significant increase in the
spontaneous release, could be because of alterations in cholesterol-dependent protein interactions,
indicating a protein-mediated inhibition of spontaneous fusion regulated by the presence of
cholesterol. Cholesterol appears to play critical modulatory roles in both spontaneous and evoked
neurotransmitter release. However, detailed mechanisms of this phenomenon have not yet been
identified.
1.5.3 cAMP-PKA pathway regulates neurotransmitter release:
Studies have implicated the role of the cAMP-PKA pathway in the regulation of
neurotransmitter release. cAMP analogs are known to increase transmitter release regulated by a
PKA-dependent increase in the number of synaptic vesicle (Baba et al., 2005). Moreover, PKA is
known to mediate synapsin phosphorylation, which modulates neurotransmission (Menegon et al.,
2006).
A study by Yoshihara et al. (2002) investigated the effect of cAMP on spontaneous and
evoked synaptic currents. To increase the cAMP level, they used forskolin, an activator of adenylyl
cyclase, and CPT-cAMP, a cAMP analog. They found that when either one was added to the
treatment group, there was an increase in the spontaneous synaptic currents. Furthermore, it is
thought that this forskolin–cAMP-dependent increase in spontaneous frequency is potentially
through activating PKA.
Studies in Drosophila have demonstrates that there is a drastic increase in the spontaneous
release in cpx null flies (Cho et al., 2015). Interestingly, the C terminus of Cpx is known to be
phosphorylated by PKA, thus indicating that it might be controlled through post-translational
modifications. Cho et al. (2015) showed that at the Drosophila NMJs, enhancement of
spontaneous release is dependent on the cAMP-PKA kinase pathway, and this process is also
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required for activity-dependent synaptic growth. The C terminus of Cpx that is involved in the
inhibition of the spontaneous fusion and most likely interacts with lipid membranes through a Cpx
7B. Cpx 7B is an amphipathic helix and is probably involved in the regulation of protein/lipid
association with the plasma and is a site for PKA phosphorylation. Research indicates that the
PKA phosphorylation of Cpx selectively enhances spontaneous release. And this enhanced
spontaneous release is required for activity-dependent synaptic growth (Cho et al., 2015) It is
possible that the cAMP–PKA cascade may influence synaptic vesicle fusion process through
various methods such as synaptic vesicle mobilization and translocation, changes in the calcium
levels through voltage-gated Ca2+ channels and regulation of synaptic vesicle fusion (Cho et
al., 2015). These studies implicate the role of the cAMP-PKA pathway in the regulation of
secretory machinery of the presynaptic neuron.
1.5.4 Cholesterol regulates kinases activity:
Protein kinases are critical molecules in many signaling pathways that modulate synaptic
responses. Neurotransmitter release is controlled in part by various protein kinases, which might
be sensitive to changes in membrane cholesterol content (Burgos et al., 2004). It is suggested that
the effects of cholesterol depletion can lead to activation of several protein kinases, which are
known regulators of neurotransmitter release at presynaptic terminals (Smith et al., 2010; CabreraPoch et al., 2004). Smith et al. (2010) found that in cerebellar neuron cultures, the rate of
spontaneous neurotransmitter release is increased after cholesterol extraction by a mechanism that
utilizes the activation of presynaptic protein kinases. Likewise, Teixeira et al. (2012) also studied
the effect of protein kinase inhibitors on spontaneous and evoked release after MβCD treatment.
Their findings suggest that cholesterol depletion facilitates protein kinase activation. These results
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further implicate that presynaptic protein kinases regulate evoked and spontaneous
neurotransmitter release, which are sensitive to changes in membrane cholesterol content.
1.5.5 Synaptic vesicles endocytosis:
The process of synaptic vesicles recycling in following synaptic vesicle fusion is known as
synaptic vesicle endocytosis. This process is critical to replenish, maintain, and regulate synaptic
vesicle pools, so that neurotransmitter release can be sustained for a prolonged period. Thus,
synaptic vesicles undergo endocytosis within the nerve terminal. This requires a constant supply
of neurotransmitter-filled synaptic vesicles through processes such clathrin-mediated endocytosis
(Chanaday et al., 2019).
1.5.5.1 Role of cholesterol during endocytosis:
Cholesterol has been implicated in mediating endocytosis (Lang et al., 2001; Dason et al.,
2010; Dason et al., 2014). Cholesterol is a required component for receptor-mediated clathrindependent endocytosis (Urs et al., 2005) and is present in synaptic vesicle membranes (Takamori
et al., 2006). A study by Dason et al. (2010) found that the depletion of cholesterol from synaptic
vesicles with MβCD decreased vesicle endocytosis and blocked synaptic transmission. Whether
cholesterol differentially regulates different forms of endocytosis has not been studied, yet these
results demonstrate that cholesterol is required for synaptic vesicle recycling.
1.5.6 Cholesterol and activity-dependent synaptic plasticity:
Synaptic plasticity is a term used to describe activity-dependent changes in synaptic
function. For example, long-term potentiation and long-term depression are changes in synaptic
responses that can be due to changes in the trafficking of receptors at the postsynaptic membrane
(Kennedy and Ehlers, 2006; Shepherd and Huganir, 2007). Cholesterol is known to regulate the
distribution of the ion channels and various receptors (Dart, 2010; Mercer et al., 2014).
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Furthermore, the cholesterol content of membranes of mammalian hippocampal neurons changes
in response to synaptic activity (Sodero et al., 2012; Brachet et al., 2015). For example, Brachet et
al. (2015) found that the long-term potentiation reduced the cholesterol content of synaptic
membranes. They observed a significant redistribution of cholesterol from its intracellular
compartment in the hippocampal neurons. In addition, Sodero et al. (2015) observed that
stimulation of glutamatergic neurotransmission induces a small but significant loss of membrane
cholesterol. This suggests that the cholesterol content of synaptic membranes can change in
response to synaptic activity.
1.5.6.1 Activity-dependent synaptic growth at the Drosophila NMJ:
Evidence in developing NMJ of Drosophila larvae have also indicated that there are
activity-dependent processes involved in synaptic development (Zhong and Wu, 2004). Crawling
of larvae in food is a simple locomotor behaviour in Drosophila. Ludwig and Cable (2003)
provided support for the increase in temperatures affects pupal development due to larval
locomotor activity being modified at different temperatures. Rearing Drosophila larvae at high
temperatures (30°C) increases larval locomotor activity, resulting in increased synaptic growth
(Sigrist et al., 2003; Zhong and Wu, 2004). Thus, these studies support that the Drosophila larvae
raised at higher temperatures have increased locomotion, which results in increased synaptic
growth.
1.6 Synaptic development in Drosophila:
Drosophila glutamatergic synapses at the larval NMJ exhibit developmental plasticity, a
process through which the neuronal connection changes during development and maturation.
During development, after the axon growth cone makes contact with the muscle, they differentiate
into the presynaptic terminals (Keshishian et al., 1996; Ruiz- Cañada and Budnik, 2006). Thus, by
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the time embryonic development is completed, a few functional synaptic boutons form on each
muscle at the NMJ (Ruiz- Cañada and Budnik, 2006). As the development progresses, synaptic
boutons are continuously added at the NMJ. This expansion occurs through either budding from a
pre-existing bouton, division of a bouton into two, or formation of a bouton from the axonal
membrane into a new bouton (Menon et al., 2013). This allows the continuous increase in the
number of boutons during development. Understanding the mechanism involved in governing the
synaptogenesis at the NMJ is a vital issue in neurobiology.
1.6.1 Role of cholesterol in synaptic development:
The formation of the synaptic networks is critical for development and plays a vital role in
long-term plasticity. Decreasing cholesterol in an embryonic brain could have serious
consequences such as respiratory distress, reduced body weight, and failure to feed because
neurons might be more sensitive to cholesterol during development (Funfschilling et al., 2012). In
mammals, the idea that brain development occurs after differentiation of astrocytes, which are glial
cells that are known to synthesize cholesterol in the brain, has sparked an interest to discover a
connection between synaptogenesis and cholesterol (Pfrieger et al., 2003). Pfrieger and Barres
(1997) investigated whether neurons form synapses in retinal ganglion cells through the release of
an unknown soluble factor released by astrocytes and oligodendrocytes. Their study identified
cholesterol to be the unknown soluble factor that promoted synaptic development.
Experimentation through active chromatographic column fractions, decrease of the cholesterol
concentration in neuronal cell cultures, and blocking cholesterol uptake via competitive antagonist
and cytochemical staining all suggested that glial cells release cholesterol that mediated synapse
development (Pfrieger et al., 2003). Additionally, glial cells are also reported in other studies on
rat ganglion cells to be responsible for the formation of synapses (Mauch et al., 2001). These
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studies found that cultured CNS neurons' ability to form synapses depends on the availability of
cholesterol at the synaptic terminals.
Defects in the synthesis and trafficking of cholesterol can also be shown to affect the
development of the nervous system. A study by Funfschilling et al. (2012) found that there is a
critical time window for the synthesis of cholesterol in neurons of the mouse brain during
development. New neurons are more susceptible to cholesterol deprivation compared to mature
neurons in cerebellar granule cells in the mouse. Additionally, Molyneaux et al. (2007) suggested
that older neurons, such as those presented in cortical layers, are more likely to be affected by
cholesterol deprivation than newer neurons in the upper cortical layers. This shows the complexity
in which cholesterol affects the neurons. Moreover, Saito et al. (2009) found that ablated activity
of squalene synthase (SQS), an enzyme for cholesterol production in the neural stem of the
embryonic central nervous system of a mouse brain, resulted in reduced brain size and neuronal
atrophy. However, the ventricular zone of the mouse brain did not undergo significant neuronal
apoptosis. Additional studies have also provided evidence that cholesterol modulates dendrite
outgrowth, dendritic branching and axonal regeneration (Goodrum et al., 2000; Fan et al., 2002).
Interestingly, differential effects on neurite outgrowth from hippocampi and cortices of rat
embryos cells in cell-cultures were found following cholesterol extraction (Ko et al., 2005). They
found that the cholesterol reduction from hippocampal neurons increases axon and dendrite
outgrowth, suggesting that the high concentration of cholesterol in these cells functions to
attenuate neurite outgrowth. In contrast, neurite outgrowth in cultured cortical neurons was
inhibited when cholesterol was extracted, suggesting that cholesterol plays the opposite role in
cortical neurons compared to hippocampal neurons. This indicates that cholesterol regulates the
outgrowth in neuronal type-specific methods.
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A recent study using the Drosophila larval NMJ found that supplementing a cholesterol
chelating agent (MβCD) in food caused a mild developmental delay, but these larvae still
maintained normal larval and muscle size reduction in the number of synaptic boutons (Huang et
al., 2018). These larvae had fewer and larger synaptic boutons at the larval NMJ, suggesting that
cholesterol is required for normal synaptic growth (Huang et al., 2018). This further provides
evidence regarding the significance of maintaining cholesterol levels for synaptic development.
1.6.2 Role of cAMP-Protein Kinase A (PKA) cascade in synaptic development:
After the formation of synapses, instructions given by presynaptic neurons can increase or
halt synaptogenesis (Munno et al., 2003). Injecting cAMP into Aplysia sensory neurons is studied
to induces long-term morphological changes (Nazif et al., 1991). Additionally, cAMP has also
been known to influence growth cone motility, neurite elongation, and synaptogenesis in cultured
neurons (Zhong et al., 1992). For example, an experiment on Lymnaea neurons has found that
number of synapses might require activation of the cAMP-PKA pathway (Munno et al., 2003).
Additionally, inhibition of the cAMP-PKA cascade has found to affect innervation, indicating that
presynaptic cAMP-PKA activity might serve to control synapse formation (Munno et al., 2003).
To study the cAMP-PKA cascade involved in the terminal development, rutabaga (rut1)
and dunce (dnc1) Drosophila mutants have been previously been used. These two mutants were
originally discovered for the roles in learning and memory (Yoshihara et al., 2002). The dnc1 allele
has reduced phosphodiesterase II activity, an enzyme that hydrolyzes cAMP (Byers et al., 1981).
Thus, cAMP levels in the dnc1 mutants will be elevated due to reduced phosphodiesterase II
activity. In contrast, the rut1 allele encodes a defect in a subunit of adenylate cyclase; thus, the rut1
mutation eliminates Ca2+/calmodulin activation of adenylate cyclase, therefore resulting in a
reduction of cAMP concentration. dnc1 mutants have increase in synaptic growth at the Drosophila
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larval NMJ (Zhong et al., 1992). On the other hand, the rut1 mutant has a decrease in synaptic
growth because of low cAMP levels (Zhong et al., 1992; Cheung et al., 1999). Additionally, the
effects of the dnc1 mutant could be counterbalanced by the rut1 mutant, as demonstrated in the
dnc1 rut1 double mutant (Zhong et al., 1992). Both mutants disrupt different aspects of the cAMP
pathway. It has also been previously studied that the activation of the cAMP responsive elementbinding protein (d-CREB), which is regulated by cAMP, is involved in the regulation of synaptic
growth at the larval NMJ (Renger et al., 2000). These results indicate that the cAMP pathway is
crucial for the regulation of nerve terminal growth and synaptic plasticity via the regulation of
second messenger cascades.
PKA is a major downstream mediator of dnc and rut genes and is known to regulate a broad
spectrum of proteins through phosphorylation. Mutations that changes the two subunits of PKA
provide a way to manipulate PKA activity levels, but viable alleles of these mutations are subjected
to behavioral and physiological changes (Renger et al., 2000). A study by Cho et al. (2015)
provided evidence that PKA-dependent phosphorylation is needed for synaptic structural plasticity
and nerve terminal growth. Moreover, constitutively active PKA (CA-PKA) is also known to be
regulating the nerve terminal growth. Third instar larvae that express CA-PKA in presynaptic
terminals displayed increased nerve terminal growth when compared to controls (Yoshihara et al.,
2005). This suggests that the activity of PKA is critical in the regulation of synaptic growth. In
summary, these studies demonstrate the role of cAMP-PKA pathway in the regulation of nerve
terminal growth at the Drosophila larval NMJ.
A study by Zhong and Wu (2004) used different cAMP pathway mutants to determine the
mechanism involved in activity-dependent plasticity. They found that the temperature-dependent
plasticity is mediated via neuronal activity changes linked to rut-dependent mechanisms.
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Furthermore, a study by Cho et al. (2015) also provided support for the requirement of PKAdependent phosphorylation of Cpx in activity-dependent synaptic structural plasticity and growth.
Given that the cholesterol content of membranes change in response to synaptic activity (Sodero et
al., 2012; Brachet et al., 2015) and existing links between the cAMP-PKA pathway (see below)
and cholesterol, investigating if cholesterol is required for activity-dependent synaptic growth may
provide further insight into the underlying mechanisms of activity-dependent synaptic growth.
1.6.3 Cholesterol-dependent effects on cAMP-PKA pathway:
The cAMP-PKA pathway is critical for many signaling processes that modulate synaptic
response and development. Cholesterol depletion can affect the activity of several cAMP-PKA
pathway components (Burgos et al., 2004; Cabrera-Poch et al., 2004; Smith et al., 2010), which
are known regulators of various processes at presynaptic terminals. In addition to direct effects on
protein kinases, cholesterol also regulates the activity of PP2A phosphatase (Wang et al., 2005).
A study by Whetton, et al. (1983) provided evidence that the depletion of rat liver plasma
membrane cholesterol inhibits adenylate cyclase activity and results in an increase in membrane
rigidity. In addition, Ayling et al. (2012) also provided evidence that the distribution and regulation
of adenylate cyclase depend on the cholesterol in the plasma membrane.
It has been well established that the lipid rafts found in the neuronal cell membrane are
enriched with cholesterol (Sebastião et al., 2013). In addition, studies have also found evidence
that the components of the cAMP-PKA pathway are embedded in the lipid in membranes. For
example, Cabrera-Pochase et al. (2004) also established that different protein kinases are
associated with lipid rafts in rat primary cortical neurons and that the cholesterol depletion of cell
membranes with MβCD dramatically alters their localization, activation, and signalling. A study
by Burgos et al. (2004) additionally supports the localization of PKA associated α and β subunits
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of G-protein in the cholesterol-based microdomains in membrane. Furthermore, previous studies
have also provided support that certain GPCRs, G-protein-coupled receptor kinase and catalytic
subunit of protein kinase A (PKA) are localized into these lipid rafts (Okamoto et al., 1998;
Steinberg, 2004). Thus, the most plausible mechanistic explanation for cholesterol dependent
effects on the cAMP-PKA pathway is that lipid raft disruption though cholesterol extraction
disrupts the activity of one or more cAMP-PKA pathway components.
In present study, I hypothesized that cholesterol extraction would reduce synaptic growth
at the Drosophila larval NMJ. I also hypothesized that this reduced synaptic growth seen following
cholesterol extraction was due to alternated cAMP-PKA signaling. Additionally, I predicted that
cholesterol was required for activity-dependent synaptic growth at NMJs. Lastly, to visualize the
cholesterol localization, I constructed a vector based on domain four (D4H) of the theta-toxin
produced by Clostridium perfringens to serve as a genetically encoded cholesterol biosensor that
can be used in Drosophila. Overall, my goal was to study the cholesterol-dependent effects on
synaptic growth and determine if these effects were through changes in the cAMP-PKA pathway.
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FIGURES

Figure 1.1 Proteins at the presynaptic terminal of synapse:
A schematic drawing of proteins found at the active zones involved during the regulation of
synaptic vesicle capture (synapsin, actin), docking (SNARE complex), priming (RIM, Rab,
Munc13) and fusion (synaptotagmin) of synaptic vesicles and voltage-gated calcium channel
(VGCC) (Bassoon, RBP , RIM , ELKS) at presynaptic terminal in rat neuronal synapses
(Adapted from Mittelstaedt et al., 2010).
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Figure 1.2 Life cycle of Drosophila melanogaster:
The image depicts the stage of the life cycle of Drosophila, completed in 10 days after the embryos
are laid on top of the food in vials with food at the bottom and cotton on top. Embryos hatched on
day 1 and followed by four days for larvae to develop in the food. During days 5-9, larvae
metamorphosis within the pupal and on day 10, maturation is complete (Adapted from Hales et
al., 2015).
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Figure 1.3 Types of boutons at the Drosophila larval NMJ:
The image shows Type Ib, Is, II, and III boutons at the Drosophila larvae neuromuscular junction
indicated by arrows. Note the size of Type 1b and type 1s boutons differ in size where 1s are
smaller than 1b boutons. Additionally, subsynaptic reticulum that surrounds boutons are labelled
with Discs-Large (Dlg) antibody (green). Type 1b boutons are surrounded by more subsynaptic
reticulum membrane as compared to 1s, whereas Dlg is absent in type II and III boutons.
Presynaptic neuronal membrane are labelled with Anti-HRP (red). Scale bars are 5 μm
(Adapted from Menon et al., 2013).
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Figure 1.4 GAL4/UAS System:
Schematic of a GAL4/UAS system. GAL4 is a yeast transcription factor which activates
transcription of its target genes by binding to the Upstream Activating Sequences (UAS) sites. As
seen in the image that the two components are located on two separate lines. The transgenic flies
that only contain one of the two constructs do not express the desired genotype. Thus to express
the desired transgene in a particular tissue, flies that contain the tissue-specific promoter of
upstream of the gene encoding GAL4 transcription factor and flies containing the corresponding
UAS must be crossed to activate the gene of interest. Hence the expression of GAL4 under a
particular promoter will result in activation of gene by binding to the UAS sequence (Image
obtained from https://igtrcn.org/gal4-uas-in-aedes-aegypti/).
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Figure 1.5 Extraction of cholesterol by methyl-β-cyclodextrin (MβCD):
Schematic of cholesterol structure (left) and cholesterol (right) extraction with MβCD (green)
(bottom). MβCD has been frequently used to deplete cells of cholesterol. MβCD are cyclic
oligomers of glucose with the ability to sequester cholesterol in its hydrophobic core. Note that
cholesterol is a hydrophobic molecules thus have a high affinity to bind to hydrophobic core of
MβCD (Image adapted from Yu et al., 2006).
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Figure 1.6 Visualizing Phase Separation-Based Kinase Reporter of Protein Kinase A:
Schematic representation of SPARK-PKA reporter where P represents the phosphate group (A).
When PKA is activated, homo-oligomeric tag 3 (HOTag3) phosphorylates and interacts with the
forkhead-associated domain 1 (FHA1), infused with HOTag3, through the phosphate group. This
leads to protein-protein interactions, resulting in phase separation and formation of fluorescent
droplets. Thus, when the kinase is inactivated, there is a diffuse fluorescence (B), and when the
kinase is activated, there is formation of concentrated fluorescent droplets (C). This method allows
SPARK-PKA based flies to detect kinase activity (Image adapted from Zhang et al., 2018).
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CHAPTER 2: EXPERIMENTAL PROCEDURES

39

2.1 Drosophila stocks and genetics:
Fly stocks were grown at room temperature (23°C) or 30°C on molasses-based fly food
medium (1.5% sucrose, 1.4% agar, 3% glucose, 1.5% cornmeal, 1% wheat germ, 1% soy flour,
3% molasses, 3.5% yeast, 0.5% propionic acid, 0.2% Tegosept and 1% ethanol in water), as
described in Anreiter et al. (2016). Wandering third-instar larvae were used for all experiments.
w1118 was used as the control strain (Dason et al., 2009). The dnc1 hypomorphic allele contains an
ethyl methanesulfonate (EMS)-induced mutation in the dnc gene (Dudia et al., 1976). This
mutation is known to decrease the phosphodiesterase II activity, leading to a higher concentration
of cAMP (Zhong et al., 1992). The rut1 allele contains an EMS-induced mutation in the rut gene
(Livingstone et al., 1984). This mutation eliminates Ca2+/CaM activation of adenylate cyclase,
resulting in a decrease in its activity (Zhong et al., 1992). The GAL4/UAS system (Brand and
Perrimon, 1993) was used for neuron-specific expression of transgenes. n-syb-GAL4 (Verstreken
et al., 2009) or C155-GAL4 (Robinow and White, 1988) were used to drive expression of
transgenes in neurons. UAS-CA-PKA was used to express a constitutively active PKA (Li et al.,
1995). UAS-CA-PKA/+ and C155-GAL4/+ were also tested as controls for any insertional effects.
UAS-LactC2-mCherry (LC2-mCherry) was used to visualize phosphatidylserine distribution in the
presynaptic terminals (Zhuo et al., 2015). UAS-SPARK-PKA was used to visualize PKA activity
(Zhong et al., 2018).
2.2 Dissections:
Dissections of wandering third instar larvae were carried on a glass dish with a magnetic
strip placed on top with a 4 cm hole in the magnetic strip (Bellen and Budnik, 2002). The larva
was pinned dorsal side up in the centre of the plate and pinned at the larva's head near the mouth
hooks and posterior spiracles. Dissections were performed in chilled Schneider's insect medium
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(Sigma, St. Louis, MO), which contains L-Glutamine to block glutaminergic synaptic transmission
and suppresses unwanted contractions of body wall muscles during dissection. A vertical incision
was made to cut along the dorsal midline from the posterior end to the anterior end. The preparation
was pinned down flat and tracheal system, internal organs, gut, fat bodies, and connective tissue
were removed to expose the CNS and musculature. The segmental nerves were cut and the CNS
was removed. The larva was then rinsed with Schneider's medium to remove any remaining
unwanted tissues.
2.3 Immunohistochemistry:
Immunohistochemistry was performed as previously described by Dason et al. (2014) and
Cantarutti et al. (2018). Briefly, the dissected larvae were fixed with the Bouin’s fixative (5%
acetic acid, 9% formaldehyde and 0.9% picric acid) for five minutes. The fixed larvae were then
washed in a phosphate-buffered saline solution containing 0.2% Triton X-100 (PBT) every fifteenminutes for an hour. Following the wash, fixed preparations were incubated in the blocking
solution (5% goat serum and BSA (1g/50ml) in PBT) for 30 minutes. Subsequently, preparations
were incubated overnight at 4°C with fluorescein isothiocyanate (FITC)-conjugated antihorseradish peroxidase antibody (HRP, 1:800 dilution, West Grove, PA) to visualize neurons and
the mouse monoclonal bruchpilot antibody (brp, 1:100 dilution; Iowa Hybridoma Bank, Iowa City,
IA) to visualize active zones or anti-green fluorescent protein mouse monoclonal 3E6 (GFP, 1:500
dilution; Invitrogen Thermo Fisher Scientific, Eugene, OR). Primary antibodies were diluted in
blocking solution. The following day, the dissected larvae were washed with 0.2% PBT for every
15 minutes for an hour. They were then incubated with the secondary antibody (1:400 dilution;
Alexa Fluor 594 goat anti-mouse or Alexa Fluor 647 goat anti-mouse; Invitrogen Thermo Fisher
Scientific, Eugene, OR) diluted in PBT for two hours at 25°C. This was followed by washing in
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PBT every 15 minutes for an hour. The samples were mounted on a slide in a drop of Permafluor
(Immunon, Pittsburgh 59 PA) and stored in a dark area at room temperature for further analysis
by the confocal microscope.
2.4 Morphological analysis/confocal microscopy:
The larval preparations were imaged using Olympus FLUOVIEW FV1000 FV10ASW
confocal microscope (Heidelberg, Germany). Images were obtained using a 60X oil immersion
objective (1.42 NA). For all experimentations, images of NMJs of abdominal segment 3 of muscle
fibres 6 and 7 were used. Images were acquired through a Z scan to make sure that the total number
of boutons on different planes were imaged. Confocal images were acquired using a step size of
0.25 μm with an approximate range of 15-32 of the number of slices.
2.5 Cholesterol extraction assay:
Cholesterol was depleted using methyl-β-cyclodextrin (MβCD), a cyclic oligosaccharide
that removes cholesterol from membranes. For chronic cholesterol extraction, flies of different
genotypes were raised on 5 or 10 mM MβCD (Sigma-Aldrich)-containing molasses-based fly food
medium as described above. These flies laid eggs on MβCD supplemented food and larvae were
allowed to develop on this food. For acute cholesterol extraction, 10 mM MβCD was mixed in
HL6 saline (Macleod et al., 2002) and was directly applied for 20 minutes to dissected larval
preparations.
2.6 Plasmids and transformation:
The pmCherry-C1 vector with D4H (mutant construct of D4, D4D434S) was provided by Dr.
Fairn (University of Toronto, ON). mCherry-D4H was digested with restriction enzymes EcoRI
and XhoI (New England BioLabs. Inc) for four hours in a thermocycler (C1000 Touch,
Thermocycler, Bio Rad Laboratories, Inc.) at 37°C to extract the D4H domain. The digested vector
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was run on a 2% agarose gel in 100mL 1xTris-Acetate-EDTA (TAE). Subsequently, the D4H
domain was gel extracted using the QIAquick® Gel Extraction Kit. Briefly, the D4H fragment
was cut from an agarose gel with a razer blade and added into the Eppendorf tube. Three volumes
of Buffer QX1 and 30 μl of QIAEX II were added and incubated for 50°C in a heat block (IsoTemp,
Fisher Scientific) for 10 minutes. After the agarose gel was dissolved, the sample was washed with
QXI and the supernatant was removed after centrifuging (Legend Micro 21R Centrifuge, Thermo
Scientific) for 30 seconds. Samples were then washed twice with 500 μl of Buffer PE and
centrifuged to remove the supernatant. The pellet was air-dried, and DNA was eluted with 20 μl
TE buffer (10 mM Tris·Cl, 1 mM EDTA 8.0). Following gel extraction, D4H was amplified by
PCR using the following pairs of primers: 5'-AAGGGAAAAATAAACTTAGATCATAGTGGA3′ (D4H sense primer) and 5′-TTAATTGTAAGTAATACTAGATCCAGGGTAT-3′ (D4H
antisense primer). The PCR amplification reaction was carried out in PCR C1000 Touch
Thermocycler (Bio Rad Laboratories, Inc.) at 98°C for 30 seconds, followed by 34 cycles (98°C
for 10 seconds, 68°C for 30 seconds, and 72°C for 60 seconds) and 72°C for 10 minutes (New
England Biolabs Phusion High-Fidelity DNA Polymerase).
The PCR product was subcloned into the pJFRC14-10XUAS-IVS-GFP-WPRE vector
(Addgene Plasmid #26223) at KpnI and NotI restriction sites. D4H was first amplified with the
following primers to create KpnI and NotI restriction sites (underscored in primer sequences): 5’TATGCGGCCGCAAGGGAAAAATAAACTTAGATC-3’

(sense

primer)

and

5’-

ATAGGTACCTTAATTGTAAGTAATACTAGATCC-3’ (antisense primer). The amplification
conditions included denaturation, annealing and extension steps, as described above. Both the
pJFRC14-10XUAS-IVS-GFP-WPRE

vector

and

amplified

D4H

were

next

digested

with KpnI and NotI restriction enzymes at 37°C for three hours. Removal of dNTP’s from the PCR
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reaction was done using shrimp alkaline phosphatase (rSAP, New England Biolabs). For this, a 20
μl reaction mixture was prepared with 10x Cutsmart Buffer, rSAP, D4H DNA and ddH2O, and
incubated at 37 °C for 30 minutes. This was followed by heat-inactivation at 65°C for 5 minutes.
Subsequently, ligations were performed using New England Biolabs products following the
manufacturer's directions. Briefly, 20 μl reaction mixture containing T4 10X DNA Ligase
Reaction Buffer, pJFRC14-10XUAS-IVS-GFP-WPRE vector DNA, Insert D4H DNA and T4
DNA Ligase was incubated for 3 hours at room temperature and then heat-inactivated at 65°C for
10 minutes.
NEB 10-beta Competent Escherichia coli strain (New England Biolabs, #C3019H) was
used for the transformation. Competent E. coli cells were removed from a -80°C freezer and
thawed on ice for 10 minutes. 1 μL of ligated plasmid was added to the cell mixture. This
suspension was chilled on ice for 30 minutes, followed by heat shock at 42°C for 30 seconds. Cells
were then placed on ice for 5 minutes. 950 µl of NEB 10-beta/Stable Outgrowth Medium was
added into cell mixture, followed by incubation at 37°C for 60 minutes. Three 10-fold serial
dilutions series of the transformation were performed. Each dilution was then spread onto
ampicillin containing LB agar plates and incubated overnight at 37°C. A PCR colony screen was
then performed. Single colonies were inoculated in LB medium containing ampicillin and grown
overnight at 37°C in a shaker. Colonies resulting from each pool were also screened for D4H using
primer 5'-AAGGGAAAAATAAACTTAGATCATAGTGGA-3′ (D4H sense primer) and 5′TTAATTGTAAGTAATACTAGATCCAGGGTAT-3′

(D4H

antisense primer)

under

the

amplification conditions described above. Colonies that contained the D4H were then further
tested by extracting the plasmid DNA using the EZ-10 Spin Column Plasmid DNA Miniprep Kit
(Molecular Biology Kit, BIO Basic Inc.). In this plasmid extraction, cell lysate supernatants were
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bound to EZ-10 Spin Column. The resin was then washed with Wash Solution, and plasmid DNA
was eluted with Elution Buffer provided in the kit. The resulting plasmids were digested with
different restrictions enzyme combinations and sequenced using Sanger Sequencing (The Centre
for Applied Genomics, SickKids, ON) to ensure that the pJFRC14-10XUAS-IVS-GFP-WPRE
vector containing the D4H sequences was present in the Escherichia coli. This vector will be sent
out for injection into Drosophila embryos by a company (Bestgene Inc.).
2.7 Bioinformatics:
Bioinformatic analyses were conducted using the Geneious Prime 2019.2.3 software
package (http://www.geneious.com). This software was used to design primers, visualization of
Sanger Sequencing, nucleotide alignments, design cloning schemes, and restriction enzyme
digests and ligations predictions.
2.8 Data analysis and statistics:
Prism 8 (version 8.4.2 (464); GraphPad Software, LLC.) was used for statistical analysis
and graphing. Fluorescence intensity was measured for regions of interest using ImageJ software
(version 1.52k; Wayne Rasband National Institutes of Health, USA). Data were verified for normal
distribution using the Shapiro-Wilk Normal Test at alpha value of 0.05. Statistical comparisons
were made using the unpaired two-tail t-test, whereas multiple comparisons were determined by
one-way ANOVA with Dunnett’s multiple comparison test. Error bars in all figures represent
standard error of the mean (SEM). Results were considered statistically significant with a P<0.05.
*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
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CHAPTER 3: RESULTS
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3.1 Cholesterol extraction reduces synaptic growth:
Studies have indicated that neurons form synapses depending on the availability of
cholesterol during synaptogenesis (Pfrieger et al., 2003; Funfschilling et al., 2012). However, in
vitro studies have pointed out that reducing cholesterol levels can increase and decrease neurite
outgrowth in different types of cultured neurons. Specifically, cholesterol reduction from
hippocampal neurons increased axon and dendrite outgrowth, whereas neurite outgrowth in
cultured cortical neurons was inhibited when cholesterol was reduced (Ko et al., 2005). A recent
study using an in vivo Drosophila larval NMJ model showed that supplementing MβCD, a
cholesterol chelating agent in food caused a reduction in synaptic growth (Huang et al., 2018).
However, the underlying mechanisms of how reduced cholesterol content of membranes affected
synaptic growth was not explored. To confirm that cholesterol extraction reduces synaptic growth
in Drosophila larval NMJ, w1118 larvae (a control strain) were fed-treated 5 mM or 10 mM MβCD
and compared to controls that were not fed MβCD. Treatment with MβCD has been demonstrated
to decrease the cholesterol content of membranes in several studies (Dason et al., 2010; Smith et
al., 2010). I stained NMJs of Drosophila third instar larvae with anti-HRP, a neuronal membrane
marker, and anti-brp, an active zone marker. Subsequently, I used confocal microscopy to image
these NMJs and counted the number of synaptic boutons and active zones on segment 3 of muscle
fibers 6 and 7. These muscle fibers are innervated by two types of axons that consist of type 1b
and 1s boutons. Boutons from these two motor neurons differ in their morphological and
physiological properties, with 1b boutons being larger (3-5 μm) than their 1s (1-3 μm) counterparts
(Atwood et al., 1993). Treatment with 10 mM MβCD caused a significant decrease in the number
of 1b and 1s boutons compared to the controls and 5 mM MβCD treatment (Fig. 3.1A, C-E). Also,
note that in larvae treated with 10 mM MβCD, some boutons appeared to be larger than the other
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two groups (Fig 3.1C, H-J), but otherwise show no obvious morphological changes. Similarly, the
number of active zones of 1s (Fig. 3.1F) and 1b (Fig. 3.1G) boutons in larvae fed 10 mM MβCD
were significantly reduced in comparison to controls. Lower concentrations of MβCD (5 mM) had
no effect on the number of boutons (Fig. 3.1A, B, D, E) or active zones (Fig. 3.1A, B, F, G) as
compared to controls. Overall, these results suggest that a proper level of cholesterol is required
for NMJ development.
3.2 Cholesterol extraction reduces PKA activity:
Protein kinases are critical molecules in many signaling proteins that modulate synaptic
responses. Inhibition of the cAMP-PKA cascade is known to influence growth cone motility,
neurite elongation, and synaptogenesis in cultured neurons (Zhong et al., 1992; Munno et al.,
2003). In addition, the cAMP-PKA pathway is also known to regulate the number of boutons at
the Drosophila larval NMJ (Cho et al., 2015). Furthermore, changes in the cholesterol content of
membranes may affect kinase activity (Smith et al., 2010). Therefore, I hypothesized that
cholesterol extraction may affect PKA activity. To examine the effects of chronic cholesterol
extraction on PKA activity, I used the GAL4/UAS system to express PKA-SPARK in presynaptic
boutons of controls, 5 mM and 10 mM MβCD fed-treated larvae. PKA-SPARK is a GFP-based
kinase reporter (Fig. 1.6) that phase-separates upon kinase activation, forming fluorescent droplets
(Zhang et al., 2018). Therefore, when kinases are inactivated, there is a diffuse fluorescence.
However, when kinases are activated, kinase substrate peptide is phosphorylated and then interacts
with phosphopeptide-binding domain; the resulting multivalent protein-protein interaction leads
to highly concentrated GFP droplets. Larvae expressing PKA-SPARK were fixed and stained with
an anti-GFP antibody. NMJs were imaged with confocal microscopy. I measured the fluorescence
intensity for type 1s and 1b boutons of muscle 6 and 7 NMJ using the ImageJ software. There was
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a significant reduction in PKA-SPARK fluorescence in 1b boutons from larvae fed 10 mM MβCD,
thus indicating that PKA activity was reduced following cholesterol extraction (Fig. 3.2A, C). A
mild but not statistically significant reduction was seen in 1s boutons (Fig. 3.2B, C). No significant
differences were found between larvae fed 5 mM MβCD and controls (Fig. 3.2A, B). Therefore,
this decrease in fluorescence intensity seems to indicate that cholesterol extraction reduces PKA
kinase activity.
In addition to studying chronic effects of cholesterol extraction on PKA activity, I also
examined the effects of acute cholesterol extraction on the PKA-SPARK biosensor. I predicted
that application of 10 mM MβCD on NMJs after dissection might show a stronger effect on PKASPARK biosensor since MβCD was being directly applied to the NMJ to extract cholesterol.
Therefore, to determine if the acute application of MβCD might show a stronger effect, I incubated
dissected third-instar larvae (grown in normal food) in HL6 saline supplemented with 10 mM
MβCD for 20 minutes before fixing and performing immunohistochemistry. I found a significant
reduction in PKA-SPARK fluorescence intensity in both 1b and 1s boutons (Fig. 3.2D-G). Acute
cholesterol extraction resulted in a greater decrease in PKA-SPARK fluorescence than was
observed when larvae were fed MβCD throughout development. Taken together, these data
suggest that cholesterol extraction reduces PKA activity.
3.3 Cholesterol and the cAMP-PKA pathway:
Drosophila cAMP-PKA mutants are known to display defects in neuronal morphology,
such as reduced growth cone motility (Kim and Wu, 1996), altered projections of mechanosensory
neurons, and altered nerve terminal growth at the larval NMJ (Corfas and Dudai, 1991; Zhong et
al., 1992). Thus, I hypothesized that the reduced synaptic growth seen following cholesterol
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extraction was due to alter cAMP-PKA signaling. To elucidate the cellular mechanisms by which
cholesterol regulates synaptic growth, I used different Drosophila mutants known to be involved
in the cAMP-PKA pathway.
Reduced cAMP levels have been revealed to reduce the number of synaptic boutons at the
Drosophila larval NMJs (Cheung et al., 1999; Zhong et al., 1992). I hypothesized that increasing
cAMP levels would rescue the reduced synaptic growth seen following cholesterol extraction. The
dnc gene encodes a phosphodiesterase II enzyme that hydrolyses cAMP (Tully, 1984 and Dudai,
1988). The dnc1 mutant reduces phosphodiesterase II activity, leading to elevated cAMP levels
(Byers et al., 1981). Consistent with previous studies (Zhong et al., 1992), I found that when dnc1
mutants when grown on normal food had significantly more 1b and 1s boutons and active zones
(Fig. 3.3A, 3.3D-G) than controls grown on normal food (Fig. 3.1). Both 5 mM and 10 mM MβCDfed larvae had a significant reduction in the number of boutons and active zones of type 1b or 1s
neurons in comparison to controls (Fig. 3.3D-G). The reduced synaptic growth was similar to that
seen in w1118 controls fed 10 mM MβCD (Fig. 3.1). Thus, I was unable to rescue the reduced
synaptic growth seen in larvae fed 10 mM MβCD by increasing cAMP levels with a dnc1 mutant.
This may suggest that cholesterol acts on adenylate cyclase or PKA directly; thus, disrupting a
cAMP-specific phosphodiesterase would not increase cAMP levels nor rescue the synaptic growth
(see discussion).
If cholesterol is acting on an adenylate cyclase, increasing PKA activity may rescue the
reduced synaptic growth seen following cholesterol extraction. To test this hypothesis, I used the
GAL4/UAS system (Brand and Perrimon, 1993) to express a constituently active PKA (CA-PKA)
in presynaptic boutons of larvae fed with MβCD. I used C155-GAL4 to drive the expression of a
UAS-CA-PKA transgene in neurons. To controls for any insertional effects, I used UAS-CA-PKA/+
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and C155-GAL4/+ controls. The w1118 control flies were crossed with UAS-CA-PKA or C155GAL4 transgenic flies. In UAS-CA-PKA/+ controls, I found that 10 mM MβCD fed-treated showed
a significant reduction in type 1b and 1s boutons (Fig. 3.4C, D, E) and active zones in 1s boutons
(Fig. 3.4C, F) compared to controls. There was a mild, but not significant, reduction in the number
of active zones in boutons of type 1b neurons of larvae fed 10 mM MβCD (Fig. 3.4G). Larvae fedtreated 5 mM MβCD showed no significant differences compared to controls (Fig. 3.4B, D-G).
Thus, cholesterol extraction with 10 mM MβCD reduces synaptic growth in UAS-CA-PKA/+
controls, consistent with what I observed with the w1118 controls (Fig. 3.1). Comparable to UASCA-PKA/+ third instar larvae, the C155-GAL4/+ larvae fed-treated 10 mM MβCD, showed a
significant reduction in the number of 1b and 1s boutons (Fig. 3.5C-E), and the number of active
zones in 1b and 1s boutons (Fig. 3.5C, F, G). Larvae fed-treated 5 mM MβCD had significantly
fewer 1s boutons compared to controls (Fig. 3.5B, D). However, the number of 1b boutons (Fig.
3.5B, 3.5E) and active zones (Fig. 3.5F, G) were not reduced when compared to the controls.
Overall the effects of cholesterol extraction on the UAS-CA-PKA/+ and C155-GAL4/+ controls
were similar to what was seen with the w1118 controls. Thus, there are no insertional effects of
UAS-CA-PKA or C155-GAL4 on synaptic growth. Results from CA-PKA mutants shows that the
number of type 1s boutons (Fig. 3.6C, D) and active zones (Fig. 3.6F) for 10 mM MβCD treated
group were significantly reduced in comparison to controls. In contrast, 10 mM MβCD fed treated
larvae showed a mild reduction, but not significant, in 1b boutons and active zones (Fig. 3.6E, G).
Similarly, 5 mM fed treated MβCD larvae show no significant decrease in 1s and 1b boutons and
active zones (Fig. 3.6B, D-G). However, I was unable to draw any conclusions from this
experiment since the CA-PKA larvae on normal food (no MβCD) did not show increased synaptic
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growth, as previously suggested by Cho et al. (2015). Moreover, CA-PKA larvae seemed to display
unhealthy behavior such as feeding problems and decreased locomotion.
3.4 Cholesterol extraction reduces activity-dependent synaptic growth:
The cholesterol content of membranes of mammalian hippocampal neurons has been found
to change in response to synaptic activity (Sodero et al., 2012; Brachet et al., 2015). Brachet et
al. (2015) provided evidence that the long-term potentiation reduced the cholesterol content in
synaptic membranes and found a significant redistribution of cholesterol from its intracellular
compartment in hippocampal neurons. It is unknown if increased synaptic activity affects the
cholesterol content of membranes in Drosophila. However, Drosophila larvae raised at higher
temperatures (30°C) have increased locomotion, which results in increased synaptic growth at the
Drosophila larval NMJ (Sigrist et al., 2003). Furthermore, the cAMP-PKA pathway has been
found to regulate activity-dependent synaptic growth (Zhong and Wu, 2004; Cho et al., 2015). I
hypothesized that extracting cholesterol would inhibit the cAMP-PKA pathway and disrupt
activity-dependent synaptic growth. Therefore, to assess whether cholesterol is required for
activity-dependent synaptic growth, I raised larvae on normal food, 5 mM MβCD and 10 mM
MβCD at room temperature (23°C) or a higher temperature (30°C). I then counted number of type
1b and type 1s boutons and active zones on segment 3 of muscle fibres 6 and 7. Statistical
comparison of larvae raised at 23°C on 10 mM MβCD showed a significant reduction in type 1s
and 1b boutons, and 1s active zones (Fig. 3.7C, D-F) compared to controls. In contrast type 1b
active zones of larvae fed with 10 mM MβCD (Fig. 3.7G) and type 1s and 1b boutons and active
zones of larvae fed with 5 mM MβCD (Fig. 3.7B, D-G) showed no differences. These results were
similar to larvae raised at 30°C on 10 mM MβCD, which showed a significant decrease in type 1s
and 1b boutons and active zones (Fig 3.8C, D-G). 1s active zones and boutons of 5 mM MβCD
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treated larvae also showed a significant decrease (Fig. 3.7D, F). While larvae fed with 5 mM
MβCD showed no difference in type 1b active zones and boutons (Fig. 3.8E, G). This suggests
that cholesterol depletion decreases activity-dependent synaptic growth seen at higher
temperatures (30°C). In addition, consistent with previous studies (Sigrist et al., 2003; Zhong and
Wu et al., 2004), I found that larvae raised on normal diet at 30°C showed a significant increase
in number of type 1b boutons, 1s boutons and active zones (Fig. 3.8H) when compared to 23°C
conditions. Results also indicated that type 1s boutons showed an increase at 5 and 10 mM MβCD
fed treatment (Fig. 3.8H-J). In contrast, type 1s and 1b active zones and 1b boutons of larvae raised
at 30°C on 5 mM and 10 mM MβCD showed no significant growth when compared to controls
(23°C) (Fig. 3.8I, J). Overall, my results indicate that the numbers of 1s and 1b boutons and active
zone were not significantly different between 23°C and 30°C in larvae fed MβCD. Since larvae on
5 mM and 10 mM MβCD at 23°C and 30°C showed a similar decrease in growth, this may suggest
that cholesterol inhibits activity-dependent growth through the cAMP-PKA pathway.
3.5 Generation of UAS-D4H-GFP flies:
To visualize the distribution of endogenous cholesterol in the cytosolic leaflet of the plasma
membrane, I constructed a D4H (mutant construct of D4, D4D434S) vector based on domain four of
the theta-toxin produced by Clostridium perfringens (Maekawa and Fairn, 2015). The D4H
domain, which has a high affinity to cholesterol, has been used as a cholesterol biosensor in other
cell types (Maekawa and Fairn, 2015). I used PCR to amplify the open reading frame of the D4H
domain

and

then

subcloned

it

into

a

pJFRC14-10XUAS-IVS-GFP-WPRE

vector

at EcoRI and XhoI restriction sites (Fig. 3.9A). The resulting vector was confirmed through PCR
amplification on agarose gel (Fig. 3.9B) and with Sanger sequencing (Fig. 3.9B) to ensure
10XUAS-IVS-D4H-GFP vector presence (Fig. 3.8C). This sequence showed a 68% sequence
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similarity when aligned with the D4H known sequence provided by Dr. Fairn (University of
Toronto, ON). Note that the Sanger Sequencing was unable to identify some of the bases, resulting
in a lower alignment similarity than expected. The resulting vector was also confirmed with
different restriction enzyme digestions (Fig 3.9 and 3.10). For this, I extracted the 10XUAS-IVSD4H-GFP

vector

from

transformed Escherichia

coli. I

digested

this

vector

with EcoRI and EcoRV (fragment sizes: 438Ibp, 2888bp, 228Ibp) and HindIII and ScaI (fragment
sizes: 5409bp, 2488bp, 1653bp) (Fig. 3.9A) and verified all digestions using the virtual gel
obtained using Geneious software (Fig. 3.9B). All digestions were also consistent with the
schematic of 10XUAS-IVS-D4H-GFP vector digestion used to identify the number of digestions
sites (Fig. 3.9C, D). I also digested the vector with EcoRI and StuI (fragment sizes: 7374bp,
2176bp) (Fig. 3.10A). This digestion was as expected according to the virtual gel obtained using
Geneious software (Fig. 3.10B). This combination confirms that the 10XUAS-IVS-D4H-GFP
sequence since StuI cuts specifically in the middle of the D4H sequence (Fig. 3.10C). Taken
together, these data confirm that the transformed Escherichia coli contained the 10XUAS-IVSD4H-GFP vector.
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Figure 3.1: Cholesterol extraction with 10mM MβCD reduces synaptic growth at larvae
NMJs:
Representative images of fixed third instar larval (w1118) NMJs stained with an anti-HRP antibody
(green) and anti-brp antibody (red). (A) Controls, (B) 5mM MβCD feeding-treatment and (C) 10
mM MβCD feeding-treatment shows that the number of boutons and active zones (AZs) of type
1b and 1s neurons were only significantly different in 10 mM MβCD treatment in comparison with
controls. This indicates that cholesterol plays a role in synaptic growth. Note also, as shown in
confocal images, that terminals for 10 mM MβCD (J) treatment possess fewer, albeit larger
boutons compared to control and 5 mM MβCD (H,I). Statistical comparisons of 5mM MβCD
feeding treatment show no significant difference in type 1s and type 1b boutons (D,E) and type 1s
and 1b active AZs (F,G) when compared to controls. In contrast, there was a significant reduction
in type 1b and 1s boutons (D,E) and type 1b and 1s AZs (F,G) compared to controls when larvae
were fed 10mM MβCD. Arrowhead points to type 1b and 1s boutons. Statistical significance was
calculated using a one-way ANOVA test (D p=0.001***; E p=0.001***; F p=0.004**;G
p=0.049*) with Dunnett’s multiple comparison test. Error bars indicate ±SEM. Scale bar, 20 μm
and 5 μm. *p < 0.05, **p < 0.01, ***p < 0.001
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Figure 3.2 Feeding 10mM MβCD reduces PKA fluorescence in type 1b boutons, and acute
application reduces SPARK florescence in both type 1s and 1b boutons: Representative
images of larvae of controls, fed-treated 5mM and fed-treated 10mM MβCD (A) stained with antiGFP (green). As shown in the comparison summary, there is no significant difference in
fluorescence intensity at type 1s boutons (B) when fed treated with MβCD at 5mM and 10mM. In
contrast, type 1b boutons (C) display a significant reduction in fluorescence intensity when fedtreated with 10 mM MβCD. PKA-SPARK was expressed in presynaptic boutons by driving UASPKA-SPARK with n-syb-GAL4. Fluorescence images of (D) controls and (E) acute application of
MβCD for 20 min on larvae NMJs show a significant reduction in fluorescence intensity as
indicated in comparison summary of type 1s boutons (F) and type 1b boutons (G), indicating
significantly reduced PKA activity. All images were obtained from Drosophila abdominal
segment 3 of muscle 6/7 NMJs of 3rd instar larvae using confocal microscopy. Arrowhead points
to type 1b and 1s boutons. Indicated comparisons were made using the unpaired two-tail t-test and
one-way ANOVA test (B p= 0.28; C p=0.007**) with Dunnett’s multiple comparison test. Error
bars indicate ±SEM. Scale bar, 5 μm. *p < 0.05, **p < 0.01, ***p < 0.001, ****P<0.0001
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Figure 3.3 Cholesterol extraction with MβCD reduces synaptic growth in dnc1 mutants:
Representative images of fixed third instar larval (dnc1) NMJs stained with anti-HRP antibody
(green) and anti-brp antibody (red). (A) Controls, (B) 5mM MβCD feeding-treatment and (C) 10
mM MβCD feeding-treatment shows that the number of boutons and active zones (AZs) of type
1b and 1s neurons were significantly reduced in 5 and 10 mM MβCD treatment group in
comparison to controls. Note also, as shown in confocal images, that terminals for 5 and 10 mM
MβCD treatment possess fewer though larger boutons. Statistical comparisons of 5 and 10 mM
MβCD feeding treatment show a significant reduction in type 1b and 1s boutons (D,E) and type
1b and 1s AZs (F,G) when compared to controls group. Statistical significance was calculated
using a one-way ANOVA test (D p=0.001***; E p=0.001***; F p=0.001***;G p=0.0001****)
with Dunnett’s multiple comparison test. Error bars indicate ±SEM. Scale bar, 20 μm. *p < 0.05,
**p < 0.01, ***p < 0.001, ****p<0.0001
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Figure 3.4 Cholesterol extraction with 10 mM MβCD reduces synaptic growth in UAS-CAPKA/+ controls:
Representative images of (A) controls (B) 5mM MβCD feeding-treatment and (C) 10 mM MβCD
feeding-treatment of NMJs stained with an anti-HRP antibody (green) and anti-brp antibody (red).
Statistical comparisons of 10 mM MβCD feeding treatment show a significant reduction in type
1b and 1s boutons (D,E) and type 1s AZs (F) compared to the controls group. In contrast, AZs of
type 1b neurons of 10mM MβCD group (G) and type 1s and 1b AZs of 5 mM MβCD treatment
show no difference when compared to controls. w1118 larvae were crossed with UAS-CA-PKA
transgenic fly. All images were obtained from Drosophila abdominal segment 3 of muscle 6/7
NMJs of 3rd instar larvae using confocal microscopy. Indicated comparisons were made using a
one-way ANOVA test (D p=0.002**; E p=0.009**; F p=0.067; G p=0.050) with Dunnett’s
multiple comparison test. Error bars indicate ±SEM. Scale bar, 20 μm. *p < 0.05, **p < 0.01, ***p
< 0.001
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Figure 3.5 Cholesterol extraction with 10 mM MβCD reduces synaptic growth in C155GAL4/+ controls:
Representative images of larvae (A) controls (B) 5mM MβCD feeding-treatment and (C) 10 mM
MβCD feeding-treatment of NMJs stained with an anti-HRP antibody (green) and anti-brp
antibody (red). Statistical comparisons of 10 mM MβCD feeding treatment show a significant
reduction in type 1b and 1s boutons (D,E), type 1s and 1b AZs (F,G) and 5 mM MβCD feedingtreatment type 1s boutons (D) when compared to the controls. In contrast, 5 mM MβCD feedingtreatment show no difference in type 1b boutons (E) and AZs (F,G) when compared to controls.
w1118 flies were crossed with C155-GAL4 transgenic flies. All images were obtained from
Drosophila abdominal segment 3 of muscle 6/7 NMJs of 3rd instar larvae using confocal
microscopy. Indicated comparisons were made using a one-way ANOVA test (D p=0.003**; E
p=0.0002***; F p=0.004**;G p=0.01*) with Dunnett’s multiple comparison test. Error bars
indicate ±SEM. Scale bar, 20 μm. *p < 0.05, **p < 0.01, ***p < 0.001
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Figure 3.6 Cholesterol extraction with 10mM reduces the number of type 1s boutons at
larvae NMJs in CA-PKA mutants: Representative images of fixed third instar larval NMJs
stained with an anti-HRP antibody (green) and anti-brp antibody (red). (A) Controls, (B) 5mM
MβCD feeding-treatment and (C) 10 mM MβCD feeding-treatment shows that the number of
boutons and active zones (AZs) of type 1b and 1s neurons. Statistical comparisons of 10mM
MβCD feeding treatment show a significant reduction in type 1s boutons (D) and active zones
(AZs) (F) when compared to controls. Additionally, 10 mM MβCD fed treated larvae showed a
mild but not significant decrease in 1b boutons (E) and AZs (G). 5 mM MβCD fed treated larvae
show no significant different at type 1s and 1b showed boutons (D,E) and AZs (E,G). Statistical
significance was calculated using a one-way ANOVA test (D p=0.05; E p=0.8; F p=0.02* ;G
p=0.08) with Dunnett’s multiple comparison test. Error bars indicate ±SEM. Scale bar, 20 μm.
*p < 0.05, **p < 0.01, ***p < 0.001
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Figure 3.7 Cholesterol extraction with 10mM MβCD at room temperature (23°C) reduces
synaptic growth at larvae NMJs: Representative images of fixed third instar larval (w1118) NMJs
stained with an anti-HRP antibody (green) and anti-brp antibody (red). (A) Controls, (B) 5mM
MβCD feeding-treatment and (C) 10 mM MβCD feeding-treatment shows that the number of
boutons and active zones (AZs) of type 1b and 1s neurons. There is a significant reduction in type
1b and 1s boutons (D,E) and type 1s AZs (F) when larvae were fed treated with 10mM MβCD. In
contrast, statistical comparisons of 5mM MβCD feeding treatment show no significant difference
in type 1s and type 1b boutons (D,E) and AZs (F,G) when compared to controls. Active zones in
1b (G) in 10 mM MβCD fed treated larvae shows a mild but not significant decrease. Statistical
significance was calculated using a one-way ANOVA test (D p=0.03*; E p=0.08; F p=0.006**;G
p=0.22) with Dunnett’s multiple comparison test. Error bars indicate ±SEM. Scale bar, 20 μm.
*p < 0.05, **p < 0.01, ***p < 0.001
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Figure 3.8 Cholesterol extraction with 10mM MβCD (30°C) reduces activity-dependent
synaptic growth, and larvae raised at 23°C and 30°C MβCD showed similar decrease in
growth:
Representative images of fixed third instar larval (w1118) NMJs stained with an anti-HRP antibody
(green) and anti-brp antibody (red). (A) Controls, (B) 5mM MβCD feeding-treatment and (C) 10
mM MβCD feeding-treatment shows that the number of boutons and active zones (AZs) of type
1b and 1s neurons. Statistical comparisons of 10mM MβCD feeding treatment show a significant
reduction in type 1s and type 1b boutons (D,E) and AZs (F,G) when compared to controls.
Additionally, 5 mM MβCD fed treated larvae show significant decrease in number of 1s boutons
and AZs (D,F). In contrast, there is a mild but not significant decrease in type 1b boutons and AZ
in 5 mM MβCD treatment (E,G) compared to controls. Drosophila larvae raised at higher
temperature of 30°C results in increased synaptic growth compared to 23°C (H). 5mM and 10 mM
MβCD fed treated larvae at 23°C and 30°C show no significant decrease in 1b boutons and active
zones and 1s active zones (I,J). 1s active zones show a decrease in growth for 5mM and 10 mM
MβCD fed treated at 23°C and 30°C temperature (H,I,J). Statistical significance was calculated
using a one-way ANOVA test (D p=0.002**; E p=0.004**; F p=0.002**;G p=0.02*) with
Dunnett’s multiple comparison test (D-G) and unpaired two-tail t-test for (H-J). Error bars indicate
±SEM. Scale bar, 20 μm. *p < 0.05, **p < 0.01, ***p < 0.001
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Figure 3.9 Cloning of fourth domain (D4H) of Clostridium perfringens theta-toxin in vector:
(A) Schematic of pJFRC14-10XUAS-IVS-D4H-GFP-WPRE vector, re-engineered to have with
D4H domain via ligation with NotI and KpnI restriction enzymes at 7,086bp site of the vector. (B)
PCR confirmation of the D4H domain being successfully extracted and amplified from vector.
(Left) Representative image of D4H obtained using the virtual gel from Geneious software and
(right) vector extracted and amplified D4H domain. The gel image is as expected according to the
virtual gel digestion. (C) Representative image shows the D4H domain sequence, which was
sequenced using Sanger Sequencing, displaying high similarity (green). Note, the arrows indicate
bases that were unidentified using this method.
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Figure 3.10 Cloning of the fourth domain (D4H) of Clostridium perfringens theta-toxin in
pJFRC14-10XUAS-IVS-D4H-GFP-WPRE in Escherichia coli:
(A) The digested pJFRC14-10XUAS-IVS-D4H-GFP-WPRE vector in agarose gel analysis. The
lanes are as follows; 1. NEB ladder, 2. EcoRI and EcoRV (3 fragments) 3. HindIII and ScaI (3
fragments) 4. negative control of undigested plasmid. All digestions are as expected according to
the virtual gel obtained using Geneious software (B). The lanes in the virtual gel are as follows: 1.
NEB ladder, 2. EcoRI and EcoRV 3. HindIII and ScaI 4. negative control of undigested plasmid.
Schematic of 10XUAS-IVS vector, re-engineered to have with D4H domain digested with
EcoRI and
EcoR,
where EcoRV cuts
at
two
different
sites
(C)
and HindIII and ScaI, where ScaI cut at two sites within the vector (D).
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Figure 3.11 Confirming the presence of the fourth domain (D4H) in pJFRC14-10XUAS-IVSD4H-GFP-WPRE vector:
(A) The digested pJFRC14-10XUAS-IVS-GFP-D4H-WPRE vector in agarose gel analysis. The
lanes are as follows; 1. NEB ladder, 2. negative control of undigested plasmid 3. EcoRI, producing
(1 fragments) 4. StuI (1 fragments) 5. EcoRI and StuI combined, (2 fragments). All digestions are
as expected according to the virtual gel obtained using Geneious software (B). The lanes in the
virtual gel are as follows: 1. NEB ladder, 2. negative control of undigested plasmid 3.
EcoRI 4. StuI 5. EcoRI and StuI. Schematic of pJFRC14-10XUAS-IVS-D4H-GFP-WPRE, reengineered to have with D4H domain, digested with EcoRI and StuI, where both cuts once at two
different sites (C). Also note that the StuI cuts in the middle of the D4H domain, confirming its
presence in the vector.
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CHAPTER 4: DISCUSSION
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Discussion
From my study, four conclusions can be drawn. First, cholesterol is required for normal
synaptic growth at Drosophila larval NMJs. Second, chronic and acute cholesterol depletion
reduces PKA-SPARK fluorescence, suggesting that cholesterol extraction reduces PKA activity.
Third, increasing cAMP levels could not rescue the reduced synaptic growth, which suggests that
cholesterol may be acting downstream of the cAMP-specific phosphodiesterase. Fourth,
cholesterol-dependent effects on the cAMP-PKA pathway may play an essential role in mediating
activity-dependent synaptic growth. The significance of these findings are discussed below.
Overall, my results suggest that cholesterol-dependent effects on synaptic growth may be due to
changes in the cAMP-PKA pathway at Drosophila larval NMJs.
4.1 Cholesterol depletion reduces synaptic growth at Drosophila larval NMJs:
Cholesterol is a critical molecule for controlling neurite outgrowth and dendritic branching
in cultured neurons during neuronal development and maturation. Axons and dendrites are
differentially affected by cholesterol deficiency (Fan et al., 2002). For example, compactin, an
inhibitor of cholesterol synthesis, inhibits dendrite outgrowth, while having little effect on axonal
outgrowth (Fan et al., 2002). Studies conducted in vitro demonstrate that cholesterol’s effects on
neuronal development also depend on neuronal subtype (Ko et al., 2005; Steinmetz et al., 2006;
Funfschilling et al., 2012). Cholesterol depletion by MβCD enhances neurite outgrowth in
hippocampal neurons and decreases neurite outgrowth in cortical neurons (Ko et al., 2012).
Similarly, Michikawa and Yanagisawa (1999) showed that the use of compactin, a 3-hydroxy-3methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on neuronal cultures prepared from
fetal rat brains, decreases neurite growth and induces neuronal death in a dose-dependent manner.
In contrast, cultured rat hippocampal neurons treated with pravastatin, also an HMG-CoA
69

reductase inhibitor, resulted in increased neurite length and branching (Pooler et al., 2006).
Moreover, lines of evidence have also suggested a critical time window and dose-dependent effects
of cholesterol on neuronal projections during development (Fan et al., 2002; Funfschilling et al.,
2012). Taken together, several studies have suggested that a decrease in neuronal cholesterol levels
affects neurite outgrowth, with some studies finding an increase in neurite outgrowth and others
finding a decrease in neurite outgrowth.
In this study, I used an in vivo system to better understand the effects of cholesterol on
nerve terminal development. I found that cholesterol depletion throughout development results in
a decrease in the number of synaptic boutons and active zones at the Drosophila larval NMJ (Fig.
3.1). I have found that higher concentrations (10 mM) of MβCD significantly reduced the number
of synaptic boutons and active zones, while lower concentrations (5 mM) of MβCD had milder
effects that were not significant (Fig 3.1D-G). Acute application (20 min) of MβCD application
had no effect on synaptic growth (Supplemental Fig. 1). Most prior investigations were conducted
on cultured neurons, such as a study by Jiang et al. (2010), which determined that neurons form
longer axons and dendrites in vitro. Some of the discrepancies between previous studies and with
my study could be due to the inability to recapitulate the in vivo environment in cultured samples
since neurons often reside in distant environments in an intact animal, thus providing conflicting
results depending on the growth conditions. Using pharmacological methods instead of genetic
ones to deplete cholesterol could also explain some of these discrepancies since it is known that
the two approaches lead to a different amount of reduction in cholesterol content. For example,
contrast to pharmacological cholesterol removal (Fan et al., 2002; Sierra et al., 2011), genetic
inactivation of cholesterol synthesis in SQS mutant neurons has shown a minor decrease in
cholesterol content (Funfschilling et al., 2012). Thus, these studies could suggest that an optimal
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concentration of cholesterol may be needed to exhibit proper development. My results indicate
that a proper level of cholesterol is required for type 1b and type 1s boutons and active zones
formation.
4.2 Cholesterol depletion affects kinase activity:
Many neuronal functions, including synaptic development, depend on the proper regulation
of synaptic proteins. Many of these proteins are known to be regulated by phosphorylation through
the balancing of various protein kinase and protein phosphatase activities (Hey-Kyoung Lee,
2010). The activity of kinases and phosphatases might be sensitive to changes in membrane
cholesterol content (Burgos et al., 2004; Cabrera-Poch et al., 2004). In Smith et al. (2010), MβCD
is also studied to affect neurotransmitter release, and these effects are blocked by the broad
spectrum protein kinase-inhibitor staurosporine, thus suggesting that changes in membrane
cholesterol content may alter protein kinase activity. Several kinases and phosphatases have been
suggested to regulate nerve terminal growth at the Drosophila larval NMJ. For example, a protein
phosphatase 2A (PP2A) has been known to be enriched in synaptic boutons and is required for
normal synaptic development at the Drosophila larval NMJ (Viquez et al., 2006). The mutant wellrounded (wrd) has a gain of function mutation in B′ regulatory subunit of PP2A and displays
overgrowth of synaptic boutons (Viquez et al., 2006). Additionally, wrd absence has demonstrated
to result in fewer synaptic boutons, abnormal cytoskeleton organization and defect in evoked
transmitter release. This implicates PP2A in regulating synaptic growth and function (Viquez et
al., 2006). Additionally, the effects of a number of kinases on nerve terminal growth have also
been studied. Protein kinase C (PKC) is known to be widely distributed in neural tissues at NMJ,
and substantial quantities are present during development (Lanuza et al., 2012; Lanuza et al.,
2014). In fact, studies in rodent preparations have found that the PKC pathway might contribute
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to activity-dependent synapse elimination and the maturation of NMJ during postnatal
development (Lanuza et al., 2010; Besalduch et al., 2011). Furthermore, at Drosophila NMJs,
atypical protein kinase C (aPKC) is also studied as being critical in NMJ development, most
probably through actin regulation in both phosphorylation and dephosphorylation events
(Ramachandran et al., 2009). The Drosophila foraging (for) gene encodes a cGMP-dependent
protein kinase (PKG) and for null mutants have increased nerve terminal growth at larval NMJs
(Dason et al., 2019). Perhaps one of the most well-studied pathways known to be directly involved
in Drosophila NMJs involves PKA (Yoshiharia et al., 2002; Munno et al., 2003; Zhong et al.,
1992). For example, a mutation in the PKA pathway is known to decrease growth cones' motility,
resulting in abnormal axonal branches and morphology, and distorted projections of
mechanosensory neurons of the third instar larval NMJs (Renger et al., 2000). Similarly, a study
by Vasin et al. (2019) showed that the growth and differentiation of new presynaptic boutons at
the Drosophila NMJ is mediated via a PKA-dependent mechanism. The additional investigation
also indicates that Drosophila mutants in PKA cascade influence the size of motor axon
projections (Zhong et al., 1992). Therefore, it appears that the PKA pathway is an essential factor
in shaping the nerve terminal development.
In the present study, I used UAS-SPARK-PKA to visualize PKA activity (Zhang et al.,
2018) and determine if cholesterol depletion was affecting PKA activity. Interestingly, I found that
feeding larvae 10 mM MβCD significantly reduced PKA-SPARK fluorescence in 1b boutons, thus
indicating that PKA activity is reduced following cholesterol extraction (Fig. 3.2A, C).
Additionally, I also found that the acute application of 10 mM MβCD shows a more substantial
effect in 10 mM MβCD in both 1b and 1s boutons (Fig. 3.2D, G). The reason for this could be
because MβCD was applied directly to the NMJs, as opposed to developing larvae taking it up
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from the food. This could explain why acute cholesterol extraction resulted in a more substantial
decrease than when larvae were fed MβCD throughout development. Overall, my data shows that
cholesterol extraction reduces PKA-SPARK fluorescence, suggesting that chronic and acute
cholesterol extraction reduces PKA activity. Zhou et al. (2012) showed an increased level of the
activated form of PKA in rat cerebellar granule neurons in a cholesterol-containing medium.
Furthermore, a study by Whetton, et al. (1983) provided evidence that the depletion of plasma
membrane cholesterol inhibits adenylate cyclase activity, which is known to be an upstream
effector of PKA. This provides evidence that cholesterol may affect PKA activity. However, these
results are in contrast to the study by Smith et al. (2010) who inferred that cholesterol depletion
may stimulate kinase activity at the plasma membrane. However, Smith et al. (2010) used a broad
spectrum protein kinase inhibitor staurosporine, and it remains possible that cholesterol-dependent
effects on neurotransmission are due to the enhanced activity of a kinase other than PKA. This
discrepancy may also be due to other differences inherent in live imaging and fixed larvae methods
of measuring PKA activity after cholesterol extraction and the experimental conditions.
Additionally, it is also likely that if PKA was activated by cholesterol reduction, I could not detect
concentrated fluorescent droplets in SPARK-based flies because of size of the boutons. Perhaps
the use of high sensitivity and spatiotemporal resolution and magnification might allow me to
better understand the absence or presence of fluorescent droplets upon cholesterol extraction to
detect kinase activity. Additionally, feeding larvae PKA inhibitors such as 4-Cyano-3methylisoquinoline or PKA Inhibitor IV to study if that has similar effects as feeding flies MβCD
could further strengthen the suggestion that cholesterol reduction decreases PKA activity in
SPARK-PKA flies.
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4.3 Cholesterol promotes NMJs development in a lipid raft-dependent manner:
A possible way in which cholesterol could modulate the NMJs growth is through the role
of the cholesterol‐rich microdomains called lipid rafts. Lipid rafts are detergent-resistant
membrane microdomains composed of sterols, proteins and sphingolipids, that are known to be
involved in the synaptic growth (Zhai et al., 2004, Huang et al., 2007; Huang et al., 2018). The
assembly of lipid rafts is cholesterol-dependent (Zhai et al., 2004). Studies have found that
cholesterol depletion by MβCD absorbs cholesterol from the membrane, thus disrupting raft
assembly in mammalian cells and Drosophila cells (Sharma et al., 2004; Zhai et al., 2004).
Findings by Dason et al. (2010) and Smith et al. (2010) have established that MβCD reduces the
cholesterol content. I found that acute MβCD application did not change distribution of
phosphatidylserine, a component of the synaptic membrane (Supplemental Fig. 2). This might
suggest that MβCD, when applied acutely have a higher affinity to remove cholesterol without
disturbing other components of rafts. This finding is consistent with a previous report that MβCD
may specifically act to remove cholesterol from the membrane, thus disrupting the formation of
membrane lipid rafts to compromise the function of raft-associated factors (Van Zanten et al.,
2006; Zhai et al., 2004; Smith et al., 2010). This also indicates that MβCD may not necessarily
affect the levels of raft-associated factors; instead, it may compromise the localization of raft
proteins. For example, several models have proposed that sterols, proteins and sphingolipids can
strongly associate with lipid rafts, and rafts can aggregate these components to link particular
proteins with distinct signaling pathways (Simons and Toomre, 2000). Together, these could
suggest that nerve terminal growth at Drosophila NMJs may be modulated by cholesterol in lipid
rafts and raft-localized factors involved in the growth of signaling pathways. Thus the NMJ
growth-promoting effect of cholesterol may depend on the assembly of normal lipid rafts.
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Even though data have suggested that cholesterol depletion affects the activity of kinases,
including PKA (Burgos et al., 2004; Cabrera-Poch et al., 2004; Smith et al., 2010), the
mechanisms linking cholesterol levels to kinase activity are not fully understood. The most
plausible mechanistic explanation for this could be that cholesterol depletion disrupts the lipid rafts
that change the localization of components of the PKA pathway that results in decreased cAMPPKA signalling. In MDCK cells, MβCD treatment affects PKA activity possibly by disrupting its
localization to lipid rafts (Burgos et al., 2004). In fact, cAMP-PKA pathway components,
including G protein-coupled receptor (GPCRs), adenylyl cyclase, Gα proteins, phosphodiesterase
and its effector molecules have all been indicated to associate within membrane rafts in variety of
tissues and cell types (Willoughby and Cooper, 2007). These components have been studied to
require distinct localizations within membrane microdomains to be functional. Since chronic and
acute cholesterol extraction reduces PKA activity, I hypothesized that membrane rafts-cholesterol
positively regulate cAMP-PKA pathway signaling in addition to known feedback mechanisms.
Moreover, this regulation is highly dependent on localization within these microdomains. Thus,
cholesterol depletion may disrupt membrane rafts (Zidovetzki and Levitan, 2007), which could
change the localization or conformation of components of the cAMP-PKA pathway within these
microdomains and result in reduced PKA activity. This effect is also dose-dependent as application
of 10 mM MβCD resulted in a larger effect than 5 mM MβCD (Fig. 3.1 and Fig. 3.2). Overall, my
results demonstrate that the activity of PKA, which regulates synaptic growth, is sensitive to
changes in membrane cholesterol content.
4.4 Cholesterol promotes NMJs development via the cAMP-PKA signaling pathway:
Multiple signaling cascades mediate Drosophila NMJ development. Numerous studies
have demonstrated a critical role for the cAMP-PKA signaling pathway in nerve terminal growth
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at the Drosophila larval NMJ. cAMP is generated by GPCR-mediated activation of adenylyl
cyclase via stimulatory proteins. cAMP then elicits highly specific cellular responses through
PKA. Presynaptic proteins such as synapsin and complexin can then be phosphorylated by PKA
to promote nerve terminal growth (Cho et al., 2015). To gain insights into the cellular mechanisms
by which cholesterol regulates synaptic development, I used various mutants known to be involved
in the cAMP-PKA pathway. Consistent with previous studies (Zhong et al., 1992), I found that
dnc1 mutants, defective in cAMP-specific phosphodiesterase that breaks down cAMP (Byers et
al., 1981), resulted in an increase in 1s and 1b boutons and active zones (Fig. 3.3). I tested if the
reduced nerve terminal growth seen in larvae fed MβCD could be rescued by increasing cAMP
levels using dnc1 mutants. Larvae raised on both 5 mM and 10 mM MβCD food showed a
significant decrease in synaptic growth (Fig. 3.3). This could be due to dnc1 mutants having
significantly more boutons than w1118 larvae (Fig. 3.1), hence cholesterol depletion has a much
stronger effect on nerve terminal growth. I predicted that if cholesterol’s effects are due to reduced
cAMP levels, then dnc1 mutants on MβCD food would not show in any reductions in synaptic
boutons. Since my results showed that dnc1 was not able to rescue the reduced synaptic growth
caused by feeding larvae MβCD, this implies that cholesterol’s effects on synaptic growth may not
be due to changes in cAMP levels. Alternatively, I predicted that reduced growth in the dnc1 might
be because cholesterol is acting downstream of cAMP and directly affecting PKA activity. Thus,
to further explore the effect of cholesterol depletion-affected downstream pathway components, I
used the GAL4/UAS system to express a consecutively active PKA (CA-PKA) in presynaptic
boutons of larvae fed MβCD. First to controls for any insertional effects, my two controls, UASCA-PKA/+ (Fig. 3.4) and C155-GAL4/+ (Fig. 3.5), showed similar decrease in growth to what I
found with the w1118 controls (Fig. 3.1) following cholesterol extraction. This indicates that any
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finding from CA-PKA would not because of unknown insertional effects in control larvae. Results
from CA-PKA rescue experiments indicate that cholesterol extraction significantly reduced 1s
boutons and active zones when larvae were fed 10 mM MβCD (Fig. 3.6C, D, F), without showing
significant decrease when larvae were feed 5 mM MβCD. However, I was unable to draw any
conclusions from this experiment since the CA-PKA larvae on normal food (no MβCD) did not
show increased synaptic growth as previously revealed by Yoshihara et al. (2005) and Cho et al.
(2015). Moreover, CA-PKA larvae seemed to display unhealthy behavior such as feeding problems
and decreased locomotion of third instar wandering out of food. This could be because C155GAL4 is expressed in all neurons, thus constitutively increasing PKA activity in all neurons might
have unexpected consequences on the behavior and development of larvae. For more conclusive
results, this rescue experiment could be repeated with D42-GAL4 (Yoshihara et al., 2005) motor
neuron-specific driver to study if cholesterol extraction could rescue the NMJs development in
CA-PKA larvae.
My findings showed that dnc1 mutants were not able to rescue the reduced synaptic growth
seen in larvae fed MβCD. This may indicate that cholesterol acts on some other pathway
components such as adenylate cyclase. rutabaga (rut) mutants have reduce adenylate cyclase basal
activity (Dudai and Zvi, 1984; Livingstone et al., 1984), leading to reduced cAMP concentration
could be studied. If cAMP levels are severely reduced, disrupting cAMP-specific
phosphodiesterase may not bring cAMP levels back to control levels. Disruption of the rut gene is
known to reduce synaptic growth at the larval NMJ (Tully, 1986; Dudai, 1988). Therefore, if
cholesterol’s effects are caused by disrupting an adenylyl cyclase, rut1 mutants on MβCD food
will not result in any further reduction in the number of synaptic boutons and active zones seen in
rut1 mutants on normal food. A weaker allele, rut2 that does not completely abolish the
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Ca2+/Calmodium activation of adenylate cyclase could be also be tested (Feany, 1992). Another
upstream component of the cAMP-PKA signaling pathway is GPCRs such as metabotropic
glutamate receptors (mGluRs), located at presynaptic boutons. Drosophila mGluRs are associated
with sterol-rich lipid microdomains, having a direct interaction with cholesterol (Eroglu et al.,
2002). mGluRs are known to modulate synaptic properties, including DmGluRA mutants that
display defects in NMJ structure, such as a reduced number of synaptic boutons accompanied by
an increase in bouton size (Bogdanik et al., 2004). Thus, further using DmGluRA larvae on MβCD
food could help establish any link between cholesterol and mGluRs. Lastly, proteins that are
phosphorylated by PKA and can regulate neurite outgrowth could also be studied to discover a
link if cholesterol is acting downstream of this pathway and directly affecting these proteins’
activity. For example, synapsin, a protein that binds to actin and clusters synaptic vesicles, is
known to show defects in activity-dependent synaptic growth and is phosphorylated by PKA
(Vasin et al., 2014; Vasin et al., 2019). Phosphorylation of complexin by PKA is also known to
regulate nerve terminal growth, consequently making it another attractive target to study (Cho et
al., 2015). Thus, it will be interesting to further explore the role of cholesterol in the nerve terminal
growth and whether these effects are due to proteins regulated by PKA.
Lastly, reduced growth in dnc1 mutant could be because cholesterol is acting on a different
pathway; thus, the extraction of cholesterol might be decreasing the number of synaptic boutons
and active zones independent of the cAMP-PKA pathway. For example, a study by Huang et
al. (2018) identified that mannosyl glucosylceramide (MacCer), a glycosphingolipid (GSL),
promotes synaptic bouton formation at the Drosophila NMJs. They found that the MacCer
positively regulates the synaptic level of wnt1/wingless (wg), whose activity depends on the
formation of normal lipid rafts to promote growth. They also found that larvae fed 20mM MβCD
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had fewer synaptic boutons. However, feeding larvae MβCD did not reduce the levels of
presynaptic MacCer. This may suggest that the suppression of synaptic growth by MβCD is due
to MacCer function through the disruption of lipid rafts rather than decrease in the MacCer levels.
This is consistent with assumption that the cholesterol extraction may disrupt the localization of
raft-associated factors to disrupt their function without affecting their levels. Alternatively, MβCD
may regulate synaptic growth through a pathway that does not involve MacCer. Bone morphogenic
protein (BMP) is an essential growth-promoting signaling in NMJs in Drosophila (Bayat et al.,
2011; Van Vactor and Sigrist, 2017). Studies have also found that BMPs associate with sterol in
the lipid rafts (North et al., 2015; Tassew et al., 2014). Thus, there is a possibility that these
pathways could also be affected by cholesterol depletion. Although my results suggest that the
alterations in synaptic growth that I observed were mainly caused by cholesterol acting on the
cAMP-PKA pathway, I cannot rule out the possibility that cholesterol depletion may have caused
reduced growth by acting on a different pathway. It is also plausible that cholesterol depletion
simultaneously acts on the cAMP-PKA pathway and other pathways in independent but parallel
ways to regulate the NMJs growth positively or negatively.
To strengthen the link between cAMP-PKA and cholesterol in synaptic growth, further
investigation could be done by measuring cAMP levels through radioimmunoassay techniques at
Drosophila NMJs as described previously (Cheung et al., 1999). cAMP levels can also be imaged
using ePAC1-camps or cAMPr (Hackley et al., 2018) to study the cAMP levels following
cholesterol depletion in live imagining. This would allow us to directly determine if cAMP levels
are reduced following cholesterol depletion. ‘FLINC’ biosensors could also be developed to
visualize kinases' live-cell biochemical activity (Mo et al., 2017). Membrane lipid rafts have
remained difficult to study because of their size, heterogeneity and dynamic nature. Using
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biochemical approaches to isolating membrane components could enable us to research lipid
composition and protein localization (Sharma et al., 2004). Combined ePAC1-camps or cAMPr
techniques to measure cAMP levels with pharmacological disruptors of membrane rafts such as
CDs might provide novel insights into the alteration in localization of adenylate cyclase after
cholesterol depletion. Thus, more sensitive and dynamic tools are needed to study cholesteroldependent regulation of cAMP-PKA pathway signaling dynamics in their native environment at
NMJs.
4.5 Cholesterol and activity-dependent synaptic growth:
The cholesterol content of neuronal membranes is known to be regulated in response to
neuronal activity. Specifically, membrane cholesterol levels are reduced in cultured hippocampal
neurons following prolonged excitatory stimulation (Sodero et al., 2012). Furthermore, the
induction of long-term potentiation in hippocampal slices results in a loss and redistribution of
cholesterol (Brachet et al., 2015). At the Drosophila larval NMJ, growth at higher temperatures
enhances nerve terminal growth due to enhanced locomotor activity (Sigrist et al., 2003; Zhang
and Wu et al., 2004). The cAMP-PKA pathway is known to regulate this activity-dependent
synaptic growth (Zhong and Wu, 2004; Cho et al., 2015). Given that my results show that
cholesterol’s effects on nerve terminal growth may be due to changes in cAMP-PKA signaling, I
tested whether cholesterol was required for this activity dependent synaptic growth (Fig. 3.7 and
3.8). Consistent with previous studies (Sigrist et al., 2003; Zhong and Wu et al., 2004), I observed
that at 30°C, there was an increase in nerve terminal growth; however, this activity-dependent
synaptic growth was largely blocked when cholesterol was depleted using MβCD. This decrease
in growth with 5 mM and 10 mM MβCD at 30°C was equivalent to 5 mM and 10 mM MβCD at
23°C. Except 1s boutons showed a small increase which could be due to incomplete suppression
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in some cases suggesting the involvement of other mechanisms as previously explained by Zhong
and Wu (1992).
Studies on hyperexcitability mutants with defects in the K+ channels or increased Na+
channel expression have increased nerve terminal projections (Budnik et al., 1990). Increased
nerve terminal growth has been observed in hyperexcitability Drosophila double mutants for K+
channel subunits such as ether a go-go (eag) and Shaker (Sh) (Budnik et al., 1990). In addition,
eag and Hyperkinetic (Hk) mutants also have increased nerve terminal due to increased excitability
(Budnik et al., 1990). These growth effects are suppressed in the triple mutant of eag Sh nap (no
action potential); a mutant that causes the reduction in the Na+ channel density (Wu et al., 1978;
Ganetzky and Wu, 1986). This suggest that increased neuronal activity effects terminal
overgrowth. Moreover, this increase in activity has been linked to cAMP levels (Renger et al.,
2000). For example, Zhong and Wu, 1992 showed that the rut-regulated cAMP pathways are an
essential link between increased neural activity and enhanced nerve terminal growth. Additionally,
they observed that the blocked terminal growth in rut mutant was rescued by expressing a wildtype rut transgene at the presynaptic terminal. Together those suggest that presynaptic rut-encoded
adenylyl cyclase activity is critical for synaptic plasticity. It should be noted that changes in
neurotransmission and synaptic growth are not always tightly linked. For example, frequenin
mutants that have increased neurotransmission and increased nerve terminal growth (Dason et al.,
2009). This suggests that some proteins may have differential effects on neurotransmission and
synaptic growth.
Increased spontaneous release is known to be required for synaptic terminal growth
(Huntwork and Littleton 2007; Cho et al., 2015). For example, Huntwork and Littleton 2007
determine that the complexin (cpxSH1) Drosophila mutant resulted in the increased frequency of
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miniature excitatory junctional potentials and increased number of active zones and synaptic
overgrowth. Extending on these findings, Cho et al. (2015) showed that activity-dependent
phosphorylation of complexin by PKA selectively enhances spontaneous release and synaptic
growth. These studies suggest that increased spontaneous release may play a vital role in synaptic
development.
My data suggest that activity-dependent synaptic growth requires cholesterol and that
cholesterol may be acting through the cAMP-PKA pathway. As mentioned above, the elevated
cAMP levels can increase the phosphorylation of proteins such as complexin and synapsin that are
involved in activity-dependent growth of nerve terminals (Koe et al., 2002; Cho et al., 2015).
Hence removing cholesterol can decrease the cAMP-PKA pathways activity, thus resulting in
reduced activity-dependent activity growth. This is supported by the fact that the numbers of 1s
and 1b boutons and active zone were not significantly different between 23°C and 30°C after
MβCD application (Fig.3.7 and 3.8). Similarly, activity-dependent synaptic growth is primarily
absent in rut1 mutants (Zhong and Wu, 2004). Therefore, it is possible that cholesterol may affect
activity-dependent synaptic growth in cAMP-PKA kinase signaling dependent manner at
Drosophila NMJs.
4.6 Generation of UAS-D4H-GFP flies:
In this study, I developed a vector based on domain four (D4H) of the theta-toxin produced
by Clostridium perfringens to serve as a genetically encoded cholesterol biosensor used in
Drosophila. This biosensor allows to visualize cholesterol in the cytosolic leaflet of the plasma
membrane. I was successfully able to amplify the open reading frame of the D4H domain and then
subcloned it into a 10XUAS-IVS-GFP vector (Fig. 3.9A). Further testing confirmed through
Sanger Sequencing (Fig. 3.9B) and restriction enzyme digestions (Fig. 3.10 and 3.11) that the
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10XUAS-IVS-D4H-GFP vector contained the D4H sequence. This probe provides an advantage
over other commonly used stains, such as filipin, which is easily photo-bleached and not used for
live-cell imaging (Maekawa et al., 2015). Additionally, filipin- and fluorophore-labelled
cholesterol can’t be distinguished from the cytosolic and exofacial leaflets of cellular membranes
as previously described (Maekawa et al., 2015). However, the D4H probe specifically labels a
cytosolic cholesterol leaflet and is suitable for live-cell imaging. In this regard, expressed D4H
could prove useful for analyzing the dynamics and organization of cholesterol in presynaptic
boutons and muscles at Drosophila larval NMJs. For example, using filipin in frog NMJs, studies
have suggested that cholesterol is enriched at active zones, which are sites of neurotransmitter
release, but absent from the adjacent areas that contain intramembrane particles (Ko and Propst,
1983). Additionally, at terminals of Torpedo, sterols are distributed in patchy fashion instead of
having a diffuse distribution (Perrelet et al., 1982). In rat cerebral cortex, the presence of sterol–
filipin complexes have also been confirmed at the presynaptic terminals and is known to change
during the development (Surchev et al., 1995). Furthermore, synaptic vesicles have a high
cholesterol content (Takamori et al., 2006) and this vesicular cholesterol is essential for synaptic
vesicle endocytosis (Dason et al., 2010). Thus, this probe can be used to examine the distribution
of cholesterol at synapses at locations such as synaptic vesicle membranes, presynaptic active
zones, synaptic vesicles and postsynaptic membranes. Furthermore, this probe could be used to
quantify cholesterol content levels and distribution following acute or chronic treatment with
MβCD. In addition, localization of cholesterol at the specific locations within presynaptic
terminals could also be determined following changes in synaptic activity. The cholesterol content
of membranes of mammalian hippocampal neurons has been indicated to change in response to
synaptic activity (Sodero et al., 2012; Brachet et al., 2015). Despite the advantages of this probe,
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caveats concerning the use of the D4H probe could be that the binding efficacy of this theta-toxin
to cholesterol may depend on the microenvironment. This limitation applies to all types of
biosensors. Some of the cholesterol access might be limited due to membrane proteins such as ion
channels and scaffolding proteins, which can bind to cholesterol, thus limiting freely accessible
cholesterol (Sheng et al., 2012; Sheng et al., 2014). Previous studies demonstrate that neighboring
phospholipids can also influence binding affinity (Flanagan et al., 2009). Cholesterol has various
presynaptic functions, including synaptic development. However, very little information is known
to what extent cholesterol is involved in these processes. This probe could be used to understand
the organization of the cholesterol distribution that reside at Drosophila NMJs.
Some of the limitations of this study might be the non-specific effects of feeding MβCD
throughout development. As mentioned above, depletion of cholesterol is known to affect other
pathways involved in the nerve terminal growth. For example, sphingolipids, such as
phosphorylated sphingosines, play a crucial role in NMJ development. Studies have identified the
upon lipid raft disruption by sterol depletion, raft-component MacCer is thought to be de-localizes
and, in turn, restricts NMJ growth (Huang et al., 2018). However, MacCer levels were not different
following MβCD treatment (Huang et al., 2018). Nevertheless, I can’t eliminate the possibility of
other pathways being affected by MβCD independent and parallel of the cAMP-PKA pathway.
Additionally, the use of MβCD is also known to affect other sterols such as ergosterol. Regardless,
studies on MβCD is known to be the most efficient as an acceptor of cellular cholesterol when
compared to carboxymethyl and 2-hydroxypropyl (Kilsdonk et al., 1995; Atger et al., 1997).
The MβCD approach from this study can be coupled with complementary approaches such
as using Drosophila mutants with impaired cholesterol trafficking. Drosophila mutants of gene
encoding cholesterol trafficking proteins such as oxysterol binding protein (osbp) and Niemann84

Pick type C1 (NPC1) might provide further insight into cholesterol-dependent nerve terminal
growth at NMJ. Also, potential live-cell, real-time imaging assay for studying membrane rafts
could help discover the precise mechanism of the role of cholesterol in the formation of NMJs.
This approach could also provide information on the cAMP-PKA signal transduction pathway
within membrane microdomains to obtain an accurate understanding of what is occurring within
the neurons.
Synaptic development is crucial for the efficient communication between neurons and
normal functioning of the nervous system. Cholesterol depletion is recognized as having drastic
consequences, such as those leading to the loss of exocytotic activity and inhibition of neuronal
growth and survival. Evidence also indicates that signal transduction, which is essential for cellular
communication, breaks down if cholesterol levels are insufficient. Altered cholesterol composition
of the neuronal membrane is also known to affect pathogenic mechanisms responsible for the
neurodegeneration. To fully comprehend complex interacting pathways controlling synaptic
development, much work needs to be done to understand the cholesterol-dependent effects on
neuronal growth due toF changes in the cAMP-PKA pathway. My research demonstrates
mechanisms linking perturbations of membrane cholesterol content to kinase activation, which
could contribute insight into synaptic dysfunction.
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SUPPLEMENTAL FIGURE

Supplemental Figure 1 Acute application of MβCD does not alter synaptic growth:
Representative images of fixed (A) controls (w1118), (B) MβCD treated preparations (w1118) using
confocal microscopy. As shown in the images, the acute application of MβCD for 20 min does not
change the gross morphology of Drosophila NMJ. Mean synaptic type 1s bouton number (C) and
type 1b bouton number (D) does not differ significantly after MβCD application. Similarly, mean
synaptic type Is active zones (AZs) (E) and type 1b AZs (F) do not differ significantly compared
to the controls. Larvae were co-stained the neuronal membrane marker horseradish peroxidase
(HRP) (green) and active zone marker bruchpilot protein (brp) (red). Arrows indicate tonic-like
type 1b (top) and phasic-like type 1s (bottom). Indicated comparisons were made using unpaired
two-tail t-test paired with controls. Error bars represent mean±SEM. Scale bar, 20 μm.
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Supplemental Figure 2: Acute application of MβCD does not alter lipid phosphatidylserine
at the larval NMJ:
(A) Controls and (B) MβCD treated images are obtained from Drosophila abdominal segment 3
of muscle 6/7 NMJs of 3rd instar larvae. Mean fluorescence intensity of type 1s bouton (C) and
type 1b boutons (D) shows no significant differences upon cholesterol extraction for 20 min,
indicating that MβCD does not alter the distribution of phosphatidylserine. NMJ was GFP with
Lactadherin C2-mCherry (LAC) (green) which binds to phosphatidylserine. Indicated
comparisons were made using unpaired two-tail t-test. Mean ± SEM is indicated in all figures.
Scale bar, 5 μm.
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